地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18372041646
传真：18995651644
邮箱：sales@amyjet.com
艾美捷科技代理Phenomenex品牌。
Phenomenex致力于开发新型分析化学解决方案，以解决工业、临床研究、政府和学术实验室中研究人员的分离和纯化挑战。
一些特色产品包括：
（1）稳健的生物制剂分析：采用新型钛 BioTi™ 生物相容性硬件，可最大限度地减少引发，四个颗粒平台可实现最佳多功能性，九个颗粒化学成分可最大限度地提高选择性和灵敏度。
（2）低流失气相色谱分离：Phenomenex Zebron 气相色谱柱产品组合涵盖广泛的应用。从最简单到最具挑战性的方法，Phenomenex的气相色谱柱技术使Phenomenex能够提供高性能和更快的分析，并实现最复杂基质的最佳分离度和分离。
（3）将样品净化时间缩短 40%：Strata-X PRO 是一种新型创新的固相萃取 （SPE） 吸附剂，可提供更快、更清洁的样品萃取方法，彻底改变传统的 SPE 方法。Strata-X PRO 提供改进且耐用的聚合物吸附剂性能，并结合基质去除技术，提供革命性的解决方案。使用更快的 SPE 方法，可将 SPE 方案的时间至少缩短 40%。无需活化或平衡的更少步骤可创建快速的 SPE 方法，而不会失去 SPE 净化样品的重要性。
（4）在任何系统上均具有超高性能：与传统的全多孔介质相比，Kinetex Core-Shell 技术在效率上有了显着的提高，可用于提高分辨率、显著提高生产率、减少溶剂消耗并降低成本。无论运行的是高效液相色谱 （HPLC） 还是超高效液相色谱 （UHPLC） 方法，Kinetex 核壳系列都能提供出色的性能。Phenomenex设计、制造和销售自己的二氧化硅和有机二氧化硅核壳颗粒。
< " data-original="http://peprotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Phenomenex品牌"> 艾美捷科技代理Phenomenex品牌
艾美捷科技特约代理Exalpha公司产品。Exalpha位于美国迈阿密，成立20余年来，坚持以切实解决客户需求为导向，提供高品质的产品。
Exalpha was founded over 20 years ago by a group of scientists dedicated to accelerating the pace of discovery in the life science arena by rapidly developing and marketing unique products at the forefront of science.
In order to develop great products, you have to ask the right questions when you start. Where some companies are satisfied with ‘average’, ‘good enough’ or ‘me too’ products, Exalpha only settles for products that answer the pertinent questions. Exalpha continually monitors scientific trends and recent literature, we strive to produce products that answer real needs. Exalpha has a long history of developing uniquely superior products that simply perform well, allowing researchers to focus on the task at hand and not on the quality of a supplier’s products.
产品主要包括：
Buffers and Reagents
Control Antibodies
Control Lysates
Kits
Proteins and Peptides
Primary Antibodies
Secondary Antibodies
Serum
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://peprotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Exalpha"> Exalpha
LGC标准物质公司隶属于LGC集团，专注于化学和生物分析，是世界领先的实验室服务、检测服务、标准物质服务、基因组服务提供商，涉及的行业包括石化、食品&饮料、临床、环境、制药、法医和生命科学等。
LGC Standard的主要产品包括：
Products and services
ATCC and Life sciences
Elemental Analysis
Food, beverages and environment
Clinical Forensic and Phytochemicals
Petroleum Standards and CRMs
Pharmaceutical
Proficiency Testing
Solvents
Training
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://peprotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LGC Standards"> LGC Standards
<艾美捷科技有限公司授权代理Katchem公司全系列产品。
产品详情请见艾美捷科技丁香通商铺或直接咨询客服人员。
https://vicbio.biomart.cn/supply/c_307368.htm
Katchem公司，位于捷克共和国Prague，是一家主要生产硼化学产品的公司，其产品主要包括：硼酸盐和碳硼酸盐簇、十硼烷（14）簇、碳硼烷、COSANes、金属硼氢化物、硼砂及其衍生物、硼烷-路易斯碱配合物、硼酸和酯、BNCT用化合物、非硼化合物、二氨基甲酸盐和催化系统等。
【产品应用场景1】
中子治疗，硼中子俘获治疗（Boron Neutron Capture Therapy，简称BNCT）。
BNCT的原理是利用发生在肿瘤细胞内的核反应摧毁癌细胞，由于同时需要中子源和B，因此，是一种二元化治疗肿瘤的新方法。BNCT的基本过程分为两部分：首先在肿瘤细胞内聚积足够量的稳定性核素B，即将一种含B的化合物引入患者体内，这种化合物与肿瘤细胞有很强的亲和力，进入体内后，迅速聚集于肿瘤细胞内，而在其它正常组织中分布很少；然后再用中子束照射肿瘤部位，使中子与肿瘤细胞内聚集的B发生B（n,α）Li核反应，B俘获中子后，形成同位素B，B迅速分裂为重粒子Li和α，肿瘤细胞被α射线和Li照射而死亡。适用于硼中子捕获治疗的含硼化合物应具备四个重要特性：对人体毒性低、对正常细胞的亲和性低、对癌细胞的亲和性高（最好可达正常细胞的3倍以上，且每克癌细胞分布的硼达到20微克以上）、能被人体迅速从正常细胞和血液移除。目前仅有两种含硼化合物应用在临床试验：Sodium Borocaptate (BSH)以及Boronophenylalanine(BPA)。
【产品应用场景2】
电池研发。
【热销产品】
【产品列表】
| 产品编码 | 产品名称 | CAS号 | 规格（g） |
| 410 | Sodium triborate dioxane | CAS [33220-35-8] | 1、5、10、25、50 |
| 458 | Cesium triborate | CAS [12007-45-3] | 1、5、10 |
| 564 | LIthium triborate dioxane | CAS [212697-88-6] | 1、5、10 |
| 315 | Triethylammonium decahydrodecaborate | CAS [12075-73-9] | 5、10、25、50、100 |
| 333 | Tetramethylammonium decahydrodecaborate | CAS [12073-87-9] | 5、10、25、50、100 |
| 493 | Sodium decahydrodecaborate | CAS [12294-20-1] | 5、10、25、50、100 |
| 459 | Ammonium decahydrodecaborate | CAS [12008-61-6] | 5、10、25、50、100 |
| 229 | Potassium decahydrodecaborate | CAS [12447-89-1] | 5、10、25、50、100 |
| 246 | Cesium decahydrodecaborate | CAS [12008-58-1] | 10、25、50、100 |
| 675 | Lithium decahydrodecaborate, trihydrate | CAS [64719-89-7 anhyd] | 5、10、25 |
| 812 | Calcium decahydrodecaborate, trihydrate | CAS [64719-84-2 anhyd] | 5、10、25 |
| 804 | Cesium decachlorodecaborate | CAS [12360-16-6] | 5、10、25、50 |
| 805 | Cesium decabromodecaborate | CAS [12356-10-4] | 5、10、25、50 |
| 803 | Cesium decaiododecaborate | CAS [88423-95-4] | 5、10、25、50 |
| 324 | Cesium tetradecahydroundecaborate | CAS [12008-72-9] | 5、10、25、50、100 |
| 453 | Triethylammonium tetradecahydroundecaborate | CAS [12106-44-4] | 5、10、25、50、100 |
| 614 | Potassium tetradecahydroundecaborate | CAS [52261-21-9] | 5、10、25、50、100 |
| 615 | Sodium tetradecahydroundecaborate | CAS [52261-23-1] | 5、10、25、50、100 |
| 372 | Trimethylammonium tetradecahydroundecaborate | CAS [12076-74-3] | 5、10、25、50、100 |
| 684 | Lithium tetradecahydroundecaborate, trihydrate | CAS [52261-22-0 anhyd.] | 1、5、10 |
| 815 | Calcium tetradecahydroundecaborate, dihydrate | 1、5、10 | |
| 290 | Triethylammonium dodecahydrododecaborate | CAS [12551-42-7] | 5、10、25、50、100、250、1000 |
| 316 | Cesium dodecahydrododecaborate | CAS [12008-75-2] | 5、10、25、50、100、250、1000 |
| 228 | Potassium dodecahydrododecaborate | CAS [12008-77-4] | 5、10、25、50、100、250、1000 |
| 257 | Sodium dodecahydrododecaborate | CAS [12008-78-5] | 5、10、25、50、100、250、1000 |
| 328 | Sodium dodecahydrododecaborate anhydrous, <0.1% water | CAS [12008-78-5] | 5、10、25、50、100、250 |
| 569 | Lithium dodecahydrododecaborate, tetrahydrate | CAS [1166383-94-3] | 5、10、25、50、100、250、1000 |
| 445 | Magnesium dodecahydrododecaborate, tetrahydrate | CAS [53572-04-6 anhyd.] | 5、10、25 |
| 446 | Cobalt dodecahydrododecaborate, dihydrate | ||
| 597 | Calcium dodecahydrododecaborate monohydrate | CAS [90157-87-2 anhyd.] | 5、10、25 |
| 492 | Rubidium dodecahydrododecaborate | CAS [12598-46-8] | 5、10、25 |
| 243 | Sodium dodecachlorododecaborate | CAS [111637-82-2] | 5、10、25、100 |
| 244 | Sodium dodecabromododecaborate | CAS [1253735-09-9] | 5、10、25、100 |
| 550 | Sodium dodecaiodododecaborate | CAS [149211-37-0] | 5、10、25、100 |
| 544 | Sodium hydroxydodecaborate | CAS [56189-13-0] | 1、5、10 |
| 347 | Cesium dodecahydroxydodecaborate | CAS [12589-26-3] | 1、5、10、50 |
| 211 | Sodium mercaptododecaborate, N-BSH | CAS [144885-51-8] | 1、5、10、25、50 |
| 266 | Cesium mercaptododecaborate, N-BSH | CAS [12448-23-6] | 1、5、10、25、50 |
| 587 | Tetramethylammonium mercaptododecaborate, N-BSH | CAS [135274-62-3] | 1、5、10、25、50 |
| 489 | syn -Octadecaborane(22) | CAS No. [21107-45-9] | 1、5、10 |
| 488 | anti -Octadecaborane(22) | CAS No. [21107-56-2] | 1、5、10 |
| 359 | Mixture of syn - and anti -octadecaboranes(22) | 1、5、10、20 | |
| 414 | Triethylammonium decahydrodecaborate 10B | ||
| 556 | Sodium decahydrodecaborate 10B, GB-10 | CAS [12373-10-3] | 1、5、10、25 |
| 258 | Triethylammonium dodecahydrododecaborate 10B | 1、10、25、50 | |
| 226 | Sodium dodecahydrododecaborate 10B | CAS [109851-98-1] | 1、10、25、50 |
| 588 | Cesium dodecahydrododecaborate 10B | CAS [109788-95-6] | 1、10、25、50 |
| 500 | Lithium dodecahydrododecaborate 10B, tetrahydrate | CAS [51745-90-5 anhyd.] | 1、10、25、50 |
| 210 | Sodium mercaptododecaborate 10B, BSH | CAS [12448-24-7] | 1、5、10、50 |
| 603 | Tetramethylammonium mercaptododecaborate 10B | CAS [130207-66-8] | 1、5、10、50 |
| 401 | Cesium mercaptododecaborate 10B | CAS [109742-44-1] | 1、5、10、50 |
| 486 | Triethylammonium dodecahydrododecaborate 11B | 1、10、25、50 | |
| 491 | Sodium dodecahydrododecaborate 11B | 1、5、10 | |
| 466 | Cesium dodecahydrododecaborate 11B | CAS [1347742-49-7] | 1、5、10 |
| 485 | Rubidium dodecahydrododecaborate 11B | CAS [1347742-48-6] | 1、2、5、10 |
| 450 | Sodium mercaptododecaborate 11B | CAS [459142-76-8] | 1、5、10 |
| 457 | Cesium carbaundecaborate | CAS [51391-30-1] | 1、5、10、25、50、100、250 |
| 456 | 7-Amino-7-carbaundecaborate | CAS [12373-10-3] | 1、5、10、25、50、100 |
| 264 | 7-Trimethylamino-7-carbaundecaborate | CAS [31117-16-5] | 1、5、10、25、50、100、250 |
| 676 | Sodium carbaundecaborate | CAS [68084-95-7] | 1、5、10 |
| 677 | Lithium carbaundecaborate, hemihydrate | CAS [2169943-32-0] | 1、5、10 |
| 251 | 1-Amino-1-carbadodecaborate | CAS [749831-19-4] | 1、5 |
| 252 | 1-Trimethylamine-1-carbadodecaborane | CAS [92468-34-3] | 1、5 |
| 212 | Trimethylammonium carbadodecaborate | CAS No.[108608-25-9] | 1、5、10、20、50 |
| 213 | Cesium carbadodecaborate | CAS No.[12539-26-3] | 1、5、10、20、50 |
| 421 | Triethylammonium carbadodecaborate | CAS No.[223548-06-9] | 1、5、10、20、50 |
| 242 | Potassium carbadodecaborate | CAS No.[92468-39-8] | 1、5、10、20、50 |
| 647 | Sodium carbadodecaborate | CAS No.[92468-38-7] | 1、5、10、20、50 |
| 648 | Lithium carbadodecaborate hemihydrate | CAS No.[92468-37-6 anhyd.] | 1、5、10、20、50 |
| 813 | Calcium carbadodecaborate trihydrate | CAS No.[2077150-90-2 anhyd.] | 1、5、10、20、50 |
| 523 | Cesium 1-methyl-1-carbadodecaborate new | CAS No.[176099-40-4] | 1、5、10 |
| 349 | Trimethylammonium 1-propyl-1-carbadodecaborate new | 1、5、10 | |
| 351 | Trimethylammonium 1-mercapto-1-carbadodecaborate new | 1、5、10 | |
| 365 | Trimethylammonium 1-hydroxy-1-carbadodecaborate new | CAS No.[2077207-91-9] | 1、5、10 |
| 366 | Trimethylammonium 1-carboxy-1-carbadodecaborate new | CAS No.[1252604-78-6] | 1、5、10 |
| 378 | Cesium closo -1-carbadecaborate | CAS No.[12539-20-7] | 1、5、10 |
| 649 | Sodium closo -1-carbadecaborate | CAS No.[94322-26-6] | 1、5、10 |
| 650 | Lithium closo -1-carbadecaborate, hydrate | CAS No.[94322-25-5 anhyd.] | 1、5、10 |
| 814 | Calcium closo -1-carbadecaborate, dihydrate | 1、5、10 | |
| 412 | Trimethylammonium 7,8-dicarbaundecaborate | CAS No.[12543-22-5] | 1、5、10、25、50、100 |
| 613 | Cesium 7,8-dicarbaundecaborate | CAS No.[63748-65-2] | 1、5、10、25、50、100 |
| 673 | Sodium 7,8-dicarbaundecaborate | CAS No.[12602-34-5] | 1、5、10、25、50、100 |
| 682 | Lithium 7,8-dicarbaundecaborate dihydrate | CAS No.[1629094-87-6 anhyd.] | 1、5、10、25、50、100 |
| 214 | Trimethylammonium 7-methyl-7,8-dicarbaundecaborate | 1、5、10、25、50 | |
| 495 | Trimethylammonium 7,9-dicarbaundecaborate | CAS No.[54531-56-5] | 1、5、10、25、50、100 |
| 384 | Cesium 7,9-dicarbaundecaborate | CAS No.[12305-33-8] | 1、5、10、25、50、100 |
| 674 | Sodium 7,9-dicarbaundecaborate | 1、5、10、25、50、100 | |
| 683 | Lithium 7,9-dicarbaundecaborate trihydrate | CAS No.[1629094-86-5 anhyd.] | 1、5、10、25、50、100 |
| 208 | Decaborane(14) | CAS [17702-41-9] | 1、5、10、25、50、100、250 |
| 419 | Bis(acetonitrile)-decabora | CAS [28377-97-1] | 5、20、100、250 |
| 238 | Bis(dimethylsulfide)-decaborane | CAS [28377-92-6] | 5、20、100、250 |
| 204 | Decaborane(14) 10B(Isotopic enrichment: 10B >99.5%) | CAS [488806-75-3] | 1、5、10、25 |
| 301 | Decaborane(14) 11B(Isotopic enrichment: 11B >99.8%) | CAS [94601-45-3] | 1、5、10、25 |
| 199 | o -Carborane | CAS No. [16872-09-6] | 1、5、10、25、50、100、250、500 |
| 209 | 1-Methyl-o -carborane | CAS No. [16872-10-9] | 5、10、25、50、100 |
| 233 | 1-Bromomethyl-o -carborane | CAS No. [19496-84-5] | 5、10、25、50、100 |
| 269 | 1,2-Dimethyl-o -carborane | CAS No. [17032-21-2] | 1、5、10 |
| 332 | 1-n-Propyl-o -carborane | CAS No. [23940-16-1] | 1、5、10 |
| 463 | 1-Hexyl-o -carborane | CAS No. [20740-05-0] | 1、5、10、25、50、100 |
| 464 | 1,2-Dihexyl-o -carborane | CAS No. [280762-92-7] | 1、5、10、25、50 |
| 203 | 1-Phenyl-o -carborane | CAS No. [16390-61-7] | 1、5、10、25、50、100 |
| 465 | 1,2-Didodecyl-o -carboran | CAS No. [943026-62-8] | 1、5、10、25、50 |
| 609 | 1-Methyl-2-propargyl-o -carborane | CAS No. [23868-57-7] | 1、2、5 |
| 318 | 1-Hydroxymetyl-o -carborane | CAS No. [19610-34-5] | 1、5、10 |
| 448 | 1,2-Bis(hydroxymethyl)-o -carborane | CAS No. [19610-37-8] | 1、5、10 |
| 297 | o -Carborane-1-carboxylic acid | CAS No. [18178-04-6] | 1、5、10 |
| 253 | o -Carborane-1,2-dicarboxylic acid | CAS No. [23835-80-5] | 1、5、10 |
| 480 | 1-Trimethylsilyl-o -carborane | CAS No. [18971-67-0] | 1、5、10、25 |
| 516 | 1-Hydroxy-o -carborane | CAS No. [23987-99-7] | 1、2、5、10 |
| 502 | 1,2-Dihydroxy-o -carboran | CAS No. [868382-62-1] | 1、2、5、10 |
| 293 | 1-Mercapto-o -carborane | CAS No. [17526-07-7] | 1、5、10、25 |
| 232 | 1,2-Dimercapto-o -carbora | CAS No. [23810-63-1] | 1、5、10、25 |
| 345 | 9-Iodo-o -carborane | CAS No. [17830-03-4] | 5、10、20 |
| 346 | 9,12-Diiodo-o -carborane | CAS No. [17702-35-1] | 5、10、20 |
| 240 | 9-Mercapto-o -carborane | CAS No. [64493-43-2] | 1、5、10 |
| 433 | 9,12-Dimercapto-o -carborane | CAS No. [75572-47-3] | 1、2、5 |
| 440 | 8,9,12-Trimercapto-o -carborane | CAS No. [1423066-18-5] | 1、2、5 |
| 200 | m -Carborane | CAS No. [16986-24-6] | 1、5、10、25、50、100、250 |
| 518 | 1-Methyl-m -carborane | CAS No. [17378-55-1] | 1、5、10、25 |
| 317 | 1-Allyl-7-methyl-m -carbor | CAS No. [20670-09-1] | 1、5、10、25 |
| 319 | 1,7-Diallyl-m -carborane | CAS No. [1232168-57-8] | 1、5、10、25 |
| 320 | 1,7-Bis(hydroxymethyl)-m -carborane | CAS No. [23924-78-9] | 1、5、10、50 |
| 298 | m -Carborane-1-carboxylic acid | CAS No. [18581-81-2] | 1、5、10 |
| 261 | 1,7-Bis(chlordimethylsilyl)-m -carborane | CAS No. [16996-48-8] | 1、5、10、50、100、250 |
| 259 | 1,7-Bis(methoxydimethylsilyl)-m -carborane | CAS No. [17631-41-3] | 1、5、10、50、100、250 |
| 321 | 1,7-Bis(hydroxydimethylsilyl)-m -carborane | CAS No. [22742-19-4] | 1、5、10、50、100、250 |
| 481 | 1-Vinyldimethylsilyl-m -carborane | 1、5、10、25 | |
| 501 | 1,7-Bis(vinyltetramethyldisiloxy)-m -carborane | CAS No. [210707-88-3] | 1、5、10、25、50 |
| 527 | 1-Hydroxy-m -carborane | CAS No. [23988-02-5] | 1、5、10 |
| 532 | 1,7-Dihydroxy-m -carbora | CAS No. [55629-26-0] | 1、5、10 |
| 496 | 1-Mercapto-m -carborane | CAS No. [56310-80-6] | 1、2、5、10 |
| 434 | 1,7-Dimercapto-m -carborane | CAS No. [23810-64-2] | 1、2、5、10 |
| 513 | 9-Mercapto-m -carborane | CAS No. [64493-44-3] | 1、2、5、10 |
| 201 | p -Carborane | CAS No. [20644-12-6] | 1、5、10、25、50 |
| 267 | p -Carborane-1,12-dicarboxylic acid | CAS No. [23087-99-2] | 1、5、10 |
| 528 | 1-Hydroxy-p -carborane | CAS No. [54360-43-9] | 1、5、10 |
| 533 | 1,12-Dihydroxy-p -carbora | CAS No. [55629-27-1] | 1、5、10 |
| 497 | 1-Mercapto-p -carborane | CAS No. [69985-41-7] | 1、2、5、10 |
| 498 | 1,12-Dimercapto-p -carborane | CAS No. [24228-77-1] | 1、2、5、10 |
| 341 | 4,5-Dicarba-arachno -nonaborane(13) new | CAS No. [113678-30-1] | 5、10、25 |
| 339 | 4,6-Dicarba-arachno -nonaborane(13) new | CAS No. [17653-38-2] | 5、10、25 |
| 340 | 6,9-Dicarba-arachno -decaborane(14) new | 5、10、25 | |
| 227 | 5,6-Dicarba-nido -decaborane(12) | CAS No. [41655-26-9] | 5、10、20 |
| 539 | Ten-vertex-o -carborane | CAS No. [41655-27-0] | 2、5 |
| 354 | Ten-vertex-m -carborane | CAS No. [23704-81-6] | 2、5 |
| 255 | Ten-vertex-p -carborane | CAS No. [23653-12-6] | 2、5 |
| 206 | o -Carborane 10B | CAS No. [760207-79-2] | 1、5、10 |
| 207 | 1-Methyl-o -carborane 10B | CAS No. [1177403-84-7] | 1、5、10 |
| 205 | m -Carborane 10B | 1、5、10 | |
| 595 | o -Carborane 11B | CAS No. [1291083-31-2] | 1、5、10 |
| 407 | m -Carborane 11B | CAS No. [1291083-36-7] | 1、5、10 |
| 271 | COSAN | CAS No.[60146-18-1] | 1、5、10、25、50、100、250 |
| 218 | Chloro-protected cesium bis(1,2-dicarbollide)-cobaltate | CAS No.[84913-29-1] | 1、5、10、25、50、100、250 |
| 393 | Bromo-protected cesium bis(1,2-dicarbollide)-cobaltate | CAS No.[84933-24-4] | 1、5、10、50 |
| 292 | COSAN dioxanate | CAS No.[188478-29-7] | 1、2、5、10、50 |
| 476 | NISAN | CAS No.[36548-55-7] | 1、5、10、25、50 |
| 483 | FESAN | CAS No.[12304-97-1] | 1、5、10、25、50 |
| 520 | Lithium COSAN | CAS No.[167568-99-2] | 1、5 |
| 517 | Sodium COSAN | CAS No.[99492-72-5] | 1、5 |
| 392 | Sodium borohydride | CAS [16940-66-2] | 50、100、250、500、1000 |
| 429 | Rubidium borohydride | CAS [20346-99-0] | 1、2、5、10 |
| 225 | Cesium borohydride | CAS [19193-36-3] | 1、2、5、10 |
| 596 | Calcium borohydride | CAS [17068-95-0] | 1、5、10、25 |
| 636 | Magnesium borohydride | CAS [16903-37-0] | 1、5、10、25 |
| 263 | Lithium borodeuteride | CAS [15246-28-3] | 1、2、5、10 |
| 361 | Lithium borohydride 10B | 1、2、5、10 | |
| 362 | Lithium borodeuteride 10B | 1、2、5、10 | |
| 323 | Lithium borohydride 11B | 1、2、5、10 | |
| 239 | Lithium borodeuteride 11B | CAS [1242073-72-8] | 1、2、5、10 |
| 363 | Lithium borohydride 7Li | 1、2、5、10 | |
| 367 | Lithium borodeuteride 7Li | 1、2、5、10 | |
| 370 | Lithium borohydride 7Li, 10B | CAS [139980-21-5] | 1、2、5、10 |
| 371 | Lithium borodeuteride 7Li, 10B | CAS [163779-14-4] | 1、2、5、10 |
| 442 | Lithium borohydride 7Li, 11B | CAS [139980-20-4] | 2、5 |
| 499 | Lithium borodeuteride 7Li,11B | CAS [163779-13-3] | 1、2、5、10 |
| 326 | Sodium borodeuteride | CAS [15681-89-7] | 5、10 |
| 202 | Sodium borohyride 10B | CAS [72901-47-4] | 1、2、5、10 |
| 373 | Sodium borodeuteride 10B | CAS [163779-18-8] | 1、2、5、10 |
| 396 | Sodium borohyride 11B | CAS [72901-46-3] | 1、2、5、10 |
| 397 | Sodium borodeuteride 11B | CAS [163779-17-7] | 1、2、5、10 |
| 379 | Potassium borodeuteride | CAS [17440-13-0] | 5、10 |
| 455 | Potassium borohyride 10B | 1、2、5、10 | |
| 417 | Potassium borodeuteride 10B | 1、2、5、10 | |
| 447 | Potassium borohyride 11B | CAS [1417734-35-0] | 1、2、5、10 |
| 413 | Potassium borodeuteride 11B | 1、2、5、10 | |
| 508 | Calcium borodeuteride | CAS [122042-59-5] | 1、2、5、10 |
| 352 | Calcium borohydride 10B | 1、2、5、10 | |
| 355 | Calcium borohydride 11B | 1、2、5、10 | |
| 220 | Calcium borodeuteride 11B | CAS [1309461-44-6] | 1、2、5、10 |
| 656 | Magnesium borohydride 11B | 1、2、5、10 | |
| 452 | Cesium borohydride 11B | CAS [1417734-38-3] | 1、2、5、10 |
| 504 | Cesium borodeuteride 11B | 1、2、5、10 | |
| 462 | Rubidium borohydride 11B | CAS [1417734-37-2] | 1、2、5、10 |
| 505 | Rubidium borodeuteride 11B | CAS [1445366-23-3] | 1、2、5、10 |
| 300 | Dimethylamine borane complex, DMAB | CAS [74-94-2] | 10、25、100、250、1000 |
| 415 | Ammonia borane complex | CAS [13774-81-7] | 10、20、50、100 |
| 415,1 | Ammonia borane complex +90% (purity >90%) | CAS [13774-81-7] | 10、20、50、100、200、500、1000 |
| 294 | Triethylamine borane complex | CAS [1722-26-5] | 10、50、100、500 |
| 221 | Dimethylsulfide borane complex, 10M solution in Me2S (d=0.8g/ml 26°C) | CAS [13292-87-0] | 100、800 |
| 375 | Ammonia borane complex 10B | CAS [77074-21-6] | 1、5、10 |
| 468 | Ammonia borane complex 11B | CAS [77069-36-4] | 1、5、10 |
| 563 | Deuteroammonia deuteroborane complex 11B | CAS [933675-78-6] | 1、2、5 |
| 577 | Deuteroammonia deuteroborane complex | CAS [20214-17-9] | 1、2、5 |
| 435 | Triethylamine deuteroborane complex | CAS [4680-65-3] | 10、25、50、100 |
| 311 | Triethylamine borane complex 10B | CAS [115959-96-1] | 10、25、50、100 |
| 449 | Triethylamine deuteroborane complex 10B | 10、25、50、100 | |
| 430 | Triethylamine borane complex 11B | 10、25、50、100 | |
| 411 | Triethylamine deuteroborane complex 11B | 10、25、50、100 | |
| 477 | Dimethylsulfide deuteroborane complex (purity > 95%) | CAS [117981-99-4] | 10、25、50、100 |
| 254 | Dimethylsulfide borane complex 10B(purity > 95%) | 10、25、50、100 | |
| 471 | Dimethylsulfide deuteroborane complex 10B(purity > 95%) | 10、25、50、100 | |
| 594 | Dimethylsulfide borane complex 11B(purity > 95%) | 10、25、50、100 | |
| 473 | Dimethylsulfide deuteroborane complex 11B(purity > 95%) | CAS [2230877-77-5] | 10、25、50、100 |
| 219 | 4-Borono-L-phenylalanine, L-BPA | CAS [76410-58-7] | 1、5、10、50 |
| 541 | Trimethylborate | CAS [121-43-7] | 5、10、50、100、400、800 |
| 268 | 4-Borono-L-phenylalanine 10B, BPA (also provide BPA produced by GMP.) | CAS [80994-59-8] | 1、10、50 |
| 436 | Trimethylborate 10B | CAS [4832-27-3] | 5、10、50、100、400、800 |
| 262 | Tri-n-butylborate 10B | CAS [207742-80-1] | 10、50、100、400、800 |
| 344 | Triphenylborate 10B | 10、50、100、400 | |
| 409 | Trimethylborate 11B | CAS [3349-42-6] | 3、10、25、50 |
| 423 | Tri-n-butylborate 11B | CAS [207742-78-7] | 10、25、50、100 |
| 431 | Triphenylborate 11B | 10、25、50、100 | |
| 210 | Sodium mercaptododecaborate 10B, BSH | CAS [12448-24-7] | 1、5、10、50 |
| 268 | 4-Borono-L-phenylalanine 10B, BPA ( also provide BPA produced by GMP.) | CAS [80994-59-8] | 1、10、50 |
| 556 | Sodium decahydrodecaborate 10B, GB-10 | CAS [666747-96-2] | 1、5、10、25 |
| 230 | TODGA | CAS [342794-43-8] | 5、10、20、50、100 |
| 296 | DIHOCA dihexyloctanoyl amide | CAS [75397-93-2] | 5、10、20、50、100 |
| 611 | TEHDGA | CAS [669087-46-1] | 5、10、20、50、100 |
| 348 | 7Li-Lithium bromide | CAS [34007-72-2] | 5、10、20、50、100 |
| 553 | 7Li-Lithium iodide | CAS [29911-74-8] | 5、10、20 |
| 308 | 7Li-Lithium chloride | CAS [20233-17-4] | 5、10、20 |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://peprotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技授权代理Katchem全系列硼化学产品"> 艾美捷科技授权代理Katchem全系列硼化学产品
艾美捷科技代理Azenta品牌。
Azenta Life Sciences致力于使世界各地的生命科学研究机构能更快地将有影响力的突破和疗法推向市场。
Azenta产品和服务包括：
（1）消耗品和仪器：Azenta Life Sciences为各种生命科学行业提供广泛的消耗品和仪器，包括生物样本库、化合物管理、基因组学、合成生物学和基础研究领域。Azenta的产品，如二维编码样品储存管、微孔板检测仪和样品管理系统，支持从基础研究到分子诊断的各种客户应用。
（2）样品储存服务：Azenta Life Sciences是样品和材料储存和管理服务的重要供应商。Azenta与各行各业合作，以满足客户的需求 - 制药、生物技术、学术和医疗保健机构。Azenta的站点遍布全球，通过提供全套可靠的冷链和超冷链样品储存解决方案，随时准备支持研究和发现、药物开发、临床研究、制药和先进的细胞疗法。
（3）样本搬迁和运输：无论是计划实验室搬迁、样本搬迁还是风险缓解以保持业务连续性，Azenta行业领先的受监管生物材料管理专家和高度专业化的冷链物流、运输和搬迁团队都会根据客户的实验室需求提供全套服务。
（4）低温冷冻机、载体和解冻：低温储存、运输和解冻需求的尖端解决方案。
< " data-original="http://peprotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Azenta品牌"> 艾美捷科技代理Azenta品牌
Lumiprobe Corporation是美国一家高品质生物技术公司，专业提供分子生物学研究用的活性荧光染料。从2006年开始，Lumiprobe公司生产并销售生命科学研究和诊断学应用的优质化学药品。产品主要有：活性染料(Reactive Dye)和SYBR Green I 染料，用于寡核苷酸合成的亚磷酰胺，点击化学和其它试剂。
Since 2006, we manufacture and sell advanced chemicals for life science research, and diagnostics. Our catalog includes fluorescent dyes, phosphoramidites for oligonucleotide synthesis, Click chemicals, and other reagents. Most of the items are kept in stock, and ready for immediate shipping to worldwide locations.
主要产品有：
（1）Reactive dyes
Dye NHS esters
Dye azides
Dye alkynes
Dye maleimides
Dye hydrazides
Carboxylic acids
Amino dyes
Tetrazines
Cycloalkyne dyes
Miscellaneous dyes
（2）Click Chemistry reagents
Non-fluorescent azides
Non-fluorescent alkynes
（3）DNA
PCR/qPCR
Modified triphosphates
Phosphoramidites
CPG solid supports
（4）Miscellaneous reagents
Bifunctional crosslinkers
Auxiliary reagents
Proteomic reagents
（5）Pegylation & PEG Linkers
（6）Ready-to-use kits
Protein labeling kits
PCR/qPCR
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技代理BioGenex品牌产品。
Biogenex位于美国旧金山，是抗原修复的发明者，是致力于研发生产准确、可靠、可重复性的高效检测方法的自动化和标准化的先驱。BioGenex拥有全面的免疫组化全自动处理系统，包括i1000抗原修复系统、i6000自动染色仪、iVISION数码成像分析系统等，具有检测诊断的高度一致性，为科研和临床诊治提供高质量的参考依据。Biogenx i 系列免疫组化全自动处理系统是使您的科研和临床病理诊断国际化的最佳途径。
BioGenex is a global market leader and an innovator in providing customer-centric molecular pathology solutions and complete walk-away automation of cell and tissue staining. We develop, manufacture and market automated slide-based staining instruments and offer a broad range of histology products for immunohistochemistry (IHC), in-situ hybridization (ISH), miRNA, in situ PCR.
BioGenex的主要产品包括：
（1）IHC
Automation
Primary Antibodies
Antigen Retrieval & Dewax
Detection Systems
Controls
Ancillaries
（2）ISH/CISH
Automation
ISH/CISH Probes
Nucleic Retrieval & Dewax
Detection Systems
Ancillaries
（3）FISH
eFISH Automation
eFISH Probes
Nucleic Retrieval & Dewax
eFISH Visualization Kits
eFISH Ancillaries
（4）miRNA
miRNA Automation
miRNA Probes & Controls
Nucleic Retrieval & Dewax
Detection Systems
Ancillaries
（5）Multiplexing & Double Staining
Automation
Antibody Cocktails
Multiplexing
Antigen Retrieval & Dewax
Detection Systems
Ancillaries
（6）Special Stains
Automation
Special Stains
Ancillaries
（7）In Situ PCR
（8）1IF
" data-original="http://peprotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理BioGenex品牌产品"> 艾美捷科技代理BioGenex品牌产品
艾美捷科技有限公司代理SIRIUS FINE CHEMICALS SICHEM GMBH公司产品。
SIRIUS FINE CHEMICALS SICHEM GMBH公司，主要提供：
点击化学工具（Si-CLICK (Click Chemistry)）
PEG试剂（Si-PEGs）
脂质及其衍生物（Si-LIPs (Lipids & Derivatives)）
磷酸肌醇试剂（Inositol Phosphates & Phosphoinositides）
核酸及其衍生物（Nucleotides & Derivatives）
API标准品及代谢底物（API Standards & Metabolites）
稳定的同位素（Stable Isotopes）
磷酸化及亚磷酸化试剂（Phosphorylation / Phosphitylation）
精细化学试剂（Fine Chemicals）
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
产品列表
| 产品名称 | 产品编号 | 分子式 |
| Click Amino Acid / trans-Cyclooct-4-en – L - Lysine (TCO4/EQ) / EQUATORIAL isomer | SC-8060 | C15H26N2O4 |
| bifunctional Cross-Linking-Amino-Acid / PrDiAzK | SC-8028 | C13H20N4O5 |
| Click Amino Acid / exo-BCN – Fmoc – L - Lysine (BCN) | SC-8038 | C32H36N2O6 |
| Cross-Linking-Amino-Acid / DiAzK | SC-8034 | C11H20N4O4 |
| Click-Amino-Acid / N3-Lys | SC-8027 | C9H17N5O4 |
| Click Amino Acid / cyclopropene – L - Lysine (CP) | SC-8017 | C12H20N2O4 |
| Click Amino Acid / endo-BCN – Fmoc – L - Lysine (BCN) | SC-8015 | C32H36N2O6 |
| Click Amino Acid / trans-Cyclooct-2-en – L - Lysine (TCO*A) | SC-8008 | C15H26N2O4 |
| Click Amino Acid / exo BCN - L - Lysine | SC-8016 | C17H26N2O4 |
| Click Amino Acid / Norbonene-CH2 – L - Lysine (NBO) | SC-8006 | C15 H24 N2 O4 * HCl |
| Click Amino Acid / rac BCN - L - Lysine | SC-8003 | C17H26N2O4 |
| Click Amino Acid / trans-Cyclooct-4-en – L - Lysine (TCO4) / AXIAL isomer | SC-8004 | C15H26N2O4 |
| Click Amino Acid / endo BCN - L - Lysine | SC-8014 | C17H26N2O4 |
| Click-Amino-Acid / PrK - HCl-salt | SC-8002 | C10H16N2O4 * HCl |
| Click Amino Acid (99%) / SCO - L - Lysine - HCO2H-salt | SC-8001 | C15H24N2O4* HCO2H |
| Click Amino Acid (95%) / SCO - L - Lysine - HCO2H-salt | SC-8000 | C15H24N2O4 * HCO2H |
| SCO-NHS carbonate | SC-8076 | C13H15NO5 |
| exo-BCN-NHS carbonate | SC-8075 | C15H17NO5 |
| endo-BCN-NHS carbonate | SC-8074 | C15H17NO5 |
| SCO-PEG7-Maleimide | SC-8305 | C32H51N3O12 |
| SCO-PEG3-Maleimide | SC-8304 | C24H35N3O8 |
| SCO-PEG2-Maleimide | SC-8303 | C22H31N3O7 |
| BCN-exo-PEG7-Maleimide | SC-8205 | C34H53N3O12 |
| BCN-exo-PEG3-Maleimide | SC-8204 | C24H33N3O7 |
| BCN-exo-PEG2-Maleimide | SC-8203 | C24H33N3O7 |
| BCN-endo-PEG7-Maleimide | SC-8105 | C34H53N3O12 |
| BCN-endo-PEG3-Maleimide | SC-8104 | C24H33N3O7 |
| BCN-endo-PEG2-Maleimide | SC-8103 | C24H33N3O7 |
| BCN-exo-PEG8-COOH | SC-8211 | C30H51NO12 |
| BCN-exo-PEG4-COOH | SC-8210 | C22H35NO8 |
| BCN-exo-PEG3-COOH | SC-8209 | C20H31NO7 |
| BCN-exo-PEG8-NHS | SC-8208 | C34H54N2O14 |
| BCN-exo-PEG4-NHS | SC-8207 | C26H38N2O10 |
| BCN-exo-PEG3-NHS | SC-8206 | C24H34N2O9 |
| BCN-endo-PEG3-NHS | SC-8106 | C24H34N2O9 |
| BCN-endo-PEG4-NHS | SC-8107 | C26H38N2O10 |
| BCN-endo-PEG8-NHS | SC-8108 | C34H54N2O14 |
| BCN-endo-PEG8-COOH | SC-8111 | C30H51NO12 |
| BCN-endo-PEG4-COOH | SC-8110 | C22H35NO8 |
| BCN-endo-PEG3-COOH | SC-8109 | C20H31NO7 |
| SCO-PEG3-COOH | SC-8309 | C18H29NO7 |
| SCO-PEG4-COOH | SC-8310 | C20H33NO8 |
| SCO-PEG8-COOH | SC-8311 | C28H49NO12 |
| SCO-PEG8-NHS | SC-8308 | C32H52N2O14 |
| SCO-PEG4-NHS | SC-8307 | C24H36N2O10 |
| SCO-PEG3-NHS | SC-8306 | C22H32N2O9 |
| SCO-PEG7-NH2 | SC-8302 | C25H46N2O9 |
| SCO-PEG3-NH2 | SC-8301 | C17H30N2O5 |
| SCO-PEG2-NH2 | SC-8300 | C15H26N2O4 |
| BCN-exo-PEG2-NH2 | SC-8200 | C17H28N2O4 |
| BCN-exo-PEG3-NH2 | SC-8201 | C19H32N2O5 |
| BCN-exo-PEG7-NH2 | SC-8202 | C27H48N2O9 |
| BCN-endo-PEG7-NH2 | SC-8102 | C27H48N2O9 |
| BCN-endo-PEG3-NH2 | SC-8101 | C19H32N2O5 |
| BCN-endo-PEG2-NH2 | SC-8100 | C17H28N2O4 |
| exo BCN - OH | SC-8033 | C10 H14 O |
| SCO - active ester (p-NPE) | SC-8032 | C15H15NO5 |
| SCO - OH | SC-8030 | C8H12O |
| endo BCN - OH | SC-8029 | C10 H14 O |
| exo BCN - active ester (p-NPE) | SC-8010 | C17H17NO5 |
| TCO4 - NHS carbonate / EQUATORIAL isomer | SC-8073 | C13H17NO5 |
| TCO4 - NHS carbonate / AXIAL isomer | SC-8072 | C13H17NO5 |
| (E)-cyclooct-4-enol / axial - TCO4 / A | SC-8018 | C8H14O |
| TCO4-PEG8-COOH | SC-8411 | C28H51NO12 |
| TCO*-PEG8-COOH | SC-8511 | C28H51NO12 |
| TCO*-PEG4-COOH | SC-8510 | C20H35NO8 |
| TCO4-PEG4-COOH | SC-8410 | C20H35NO8 |
| TCO4-PEG3-COOH | SC-8409 | C18H31NO7 |
| TCO*-PEG3-COOH | SC-8509 | C20H31NO7 |
| TCO*-PEG8-NHS | SC-8508 | C32H54N2O14 |
| TCO4-PEG8-NHS | SC-8408 | C32H54N2O14 |
| TCO4-PEG4-NHS | SC-8407 | C24H38N2O10 |
| TCO*-PEG4-NHS | SC-8507 | C24H38N2O10 |
| TCO*-PEG3-NHS | SC-8506 | C22H34N2O9 |
| TCO4-PEG3-NHS | SC-8406 | C22H34N2O9 |
| TCO*-PEG7-Maleimide | SC-8505 | C32H53N3O12 |
| TCO*-PEG3-Maleimide | SC-8504 | C24H37N3O8 |
| TCO*-PEG2-Maleimide | SC-8503 | C22H33N3O7 |
| TCO4-PEG7-Maleimide | SC-8405 | C32H53N3O12 |
| TCO4-PEG3-Maleimide | SC-8404 | C24H37N3O8 |
| TCO4-PEG2-Maleimide | SC-8403 | C22H33N3O7 |
| TCO*-PEG2-NH2 | SC-8500 | C15H28N2O4 |
| TCO*-PEG3-NH2 | SC-8501 | C17H32N2O5 |
| TCO*-PEG7-NH2 | SC-8502 | C25H48N2O9 |
| TCO4-PEG7-NH2 | SC-8402 | C25H48N2O9 |
| TCO4-PEG3-NH2 | SC-8401 | C17H32N2O5 |
| TCO4-PEG2-NH2 | SC-8400 | C15H28N2O4 |
| (E)-cyclooct-4-en active ester / TCO/E- active ester (p-NPE) / equatorial | SC-8024 | C15H17NO5 |
| (E)-cyclooct-4-en active ester / TCO4 / A- active ester (p-NPE) / axial | SC-8019 | C15H17NO5 |
| TCO*A - active ester (p-NPE) | SC-8007 | C15H17NO5 |
| Fluorescent-PEG8-Me-Tet | SC-8817 | C54H68N8O13 |
| Fluorescent-PEG4-Me-Tet | SC-8816 | C46H52N8O9 |
| Fluorescent-PEG3-Me-Tet | SC-8815 | C44H48N8O8 |
| Me-Tet-PEG8-NHBoc | SC-8820 | C34H56N6O11 |
| Me-Tet-PEG4-NHBoc | SC-8819 | C26H40N6O7 |
| Me-Tet-PEG3-NHBoc | SC-8818 | C24H36N6O6 |
| Biotin-PEG8-Me-Tet | SC-8814 | C39H62N8O11S |
| Biotin-PEG4-Me-Tet | SC-8813 | C31H46N8O7S |
| Biotin-PEG3-Me-Tet | SC-8812 | C29H42N8O6S |
| Me-Tet-PEG9-COOH | SC-8811 | C32H51N5O12 |
| Me-Tet-PEG5-COOH | SC-8810 | C24H35N5O8 |
| Me-Tet-PEG4-COOH | SC-8809 | C22H31N5O7 |
| Me-Tet-PEG9-NHS | SC-8808 | C36H54N6O14 |
| Me-Tet-PEG5-NHS | SC-8807 | C28H38N6O10 |
| Me-Tet-PEG4-NHS | SC-8806 | C26H34N6O9 |
| Me-Tet-PEG8-Maleimide | SC-8805 | C36H53N7O12 |
| Me-Tet-PEG4-Maleimide | SC-8804 | C28H37N7O8 |
| Me-Tet-PEG3-Maleimide | SC-8803 | C26H33N7O7 |
| Me-Tet-PEG8-NH2 - HCl salt | SC-8802 | C29H48N6O9 + HCl |
| Me-Tet-PEG4-NH2 | SC-8801 | C21H32N6O5 |
| Me-Tet-PEG3-NH2 | SC-8800 | C19H28N6O4 |
| Aminopentyl - Tetrazine - HCl-salt | SC-1193 | C18H20N8O * HCl |
| Tetrazine active ester (Tetrazine-NHS) | SC-1194 | C17H11N7O4 |
| Aminopropyl - Tetrazine - HCl-salt | SC-1192 | C16H16N8O * HCl |
| Methyl-Tetrazine - Amine- HCO2H-salt | SC-1191 | C10H11N5* HCO2H |
| Tetrazine - Amine - HCO2H-salt | SC-1190 | C9H9N5 * HCO2H |
| N3-PEG8-t-butyl ester | SC-8923 | C23H45N3O10 |
| N3-PEG5-t-butyl ester | SC-8922 | C17H33N3O7 |
| N3-PEG4-t-butyl ester | SC-8921 | C15H29N3O6 |
| N3-PEG3-t-butyl ester | SC-8920 | C13H25N3O5 |
| Boc-N-Amido-PEG7-N3 | SC-8912 | C21H42N4O9 |
| Boc-N-Amido-PEG3-N3 | SC-8911 | C13H26N4O5 |
| Boc-N-Amido-PEG2-N3 | SC-8910 | C11H22N4O4 |
| Boc-N-Amido-PEG4-Alkyne | SC-8900 | C16H29NO6 |
| Boc-N-Amido-PEG3-Alkyne | SC-8039 | C14H25NO5 |
| TAMRA-PEG8-Alkyne | SC-8717 | C44H57N3O12 |
| TAMRA-PEG4-Alkyne | SC-8716 | C36H41N3O8 |
| TAMRA-PEG3-Alkyne | SC-8715 | C34H37N3O7 |
| TAMRA-PEG7-N3 | SC-8714 | C41H54N6O11 |
| TAMRA-PEG3-N3 | SC-8713 | C33H38N6O7 |
| TAMRA-PEG2-N3 | SC-8712 | C31H34N6O6 |
| Biotin-PEG8-Alkyne | SC-8617 | C29H51N3O10S |
| Biotin-PEG4-Alkyne | SC-8616 | C21H35N3O6S |
| Biotin-PEG3-Alkyne | SC-8615 | C19H31N3O5S |
| Biotin-PEG7-N3 | SC-8614 | C26H48N6O9S |
| Biotin-PEG3-N3 | SC-8613 | C18H32N6O5S |
| Biotin-PEG2-N3 | SC-8612 | C16H28N6O4S |
| Click-Amino-Acid / PrK - HCl-salt | SC-8002 | C10H16N2O4 * HCl |
| Alkyne - PEG2 | SC-0063 | C7H12O3 |
| Azido - PEG1 | SC-0062 | C4H9N3O2 |
| Biotin-PEG8-Alkyne | SC-8617 | C29H51N3O10S |
| Biotin-PEG4-Alkyne | SC-8616 | C21H35N3O6S |
| Biotin-PEG3-Alkyne | SC-8615 | C19H31N3O5S |
| Alkyne - PEG2 - TCA | SC-0067 | C9H12Cl3NO3 |
| Alkyne - PEG2 - CM | SC-0065 | C8H13ClO3 |
| Alkyne - PEG2 | SC-0063 | C7H12O3 |
| TAMRA-PEG7-N3 | SC-8714 | C41H54N6O11 |
| TAMRA-PEG3-N3 | SC-8713 | C33H38N6O7 |
| TAMRA-PEG2-N3 | SC-8712 | C31H34N6O6 |
| Biotin-PEG7-N3 | SC-8614 | C26H48N6O9S |
| Biotin-PEG3-N3 | SC-8613 | C18H32N6O5S |
| Biotin-PEG3-CoenzymeA | SC-8618 | C46H75N12O24P3S2+3NH3 |
| Bis-Cyano-PEG9 | SC-8932 | C22H40N2O9 |
| Bis-Cyano-PEG5 | SC-8931 | C14H24N2O5 |
| Bis-Cyano-PEG4 | SC-8930 | C12H20N2O4 |
| N3-PEG8-t-butyl ester | SC-8923 | C23H45N3O10 |
| N3-PEG5-t-butyl ester | SC-8922 | C17H33N3O7 |
| N3-PEG4-t-butyl ester | SC-8921 | C15H29N3O6 |
| N3-PEG3-t-butyl ester | SC-8920 | C13H25N3O5 |
| Boc-N-Amido-PEG7-N3 | SC-8912 | C21H42N4O9 |
| Boc-N-Amido-PEG3-N3 | SC-8911 | C13H26N4O5 |
| Boc-N-Amido-PEG2-N3 | SC-8910 | C11H22N4O4 |
| Boc-N-Amido-PEG4-Alkyne | SC-8900 | C16H29NO6 |
| Boc-N-Amido-PEG3-Alkyne | SC-8039 | C14H25NO5 |
| Fluorescent-PEG8-Me-Tet | SC-8817 | C54H68N8O13 |
| Fluorescent-PEG4-Me-Tet | SC-8816 | C46H52N8O9 |
| Fluorescent-PEG3-Me-Tet | SC-8815 | C44H48N8O8 |
| TAMRA-PEG8-Alkyne | SC-8717 | C44H57N3O12 |
| TAMRA-PEG4-Alkyne | SC-8716 | C36H41N3O8 |
| TAMRA-PEG3-Alkyne | SC-8715 | C34H37N3O7 |
| TAMRA-PEG7-N3 | SC-8714 | C41H54N6O11 |
| TAMRA-PEG3-N3 | SC-8713 | C33H38N6O7 |
| TAMRA-PEG2-N3 | SC-8712 | C31H34N6O6 |
| TAMRA-PEG8-COOH | SC-8711 | C44H59N3O14 |
| TAMRA-PEG4-COOH | SC-8710 | C36H43N3O10 |
| TAMRA-PEG3-COOH | SC-8709 | C34H39N3O9 |
| TAMRA-PEG8-NHS | SC-8708 | C48H62N4O16 |
| TAMRA-PEG4-NHS | SC-8707 | C40H46N4O12 |
| TAMRA-PEG3-NHS | SC-8706 | C38H42N4O11 |
| TAMRA-PEG7-Maleimide | SC-8705 | C48H61N5O14 |
| TAMRA-PEG3-Maleimide | SC-8704 | C40H45N5O10 |
| TAMRA-PEG2-Maleimide | SC-8703 | C38H41N5O9 |
| TAMRA-PEG7-NH2 | SC-8702 | C41H56N4O11 |
| TAMRA-PEG3-NH2 | SC-8701 | C33H40N4O7 |
| TAMRA-PEG2-NH2 | SC-8700 | C31H36N4O6 |
| Me-Tet-PEG8-NHBoc | SC-8820 | C34H56N6O11 |
| Me-Tet-PEG4-NHBoc | SC-8819 | C26H40N6O7 |
| Me-Tet-PEG3-NHBoc | SC-8818 | C24H36N6O6 |
| Biotin-PEG8-Me-Tet | SC-8814 | C39H62N8O11S |
| Biotin-PEG4-Me-Tet | SC-8813 | C31H46N8O7S |
| Biotin-PEG3-Me-Tet | SC-8812 | C29H42N8O6S |
| Me-Tet-PEG9-COOH | SC-8811 | C32H51N5O12 |
| Me-Tet-PEG5-COOH | SC-8810 | C24H35N5O8 |
| Me-Tet-PEG4-COOH | SC-8809 | C22H31N5O7 |
| Me-Tet-PEG9-NHS | SC-8808 | C36H54N6O14 |
| Me-Tet-PEG5-NHS | SC-8807 | C28H38N6O10 |
| Me-Tet-PEG4-NHS | SC-8806 | C26H34N6O9 |
| Me-Tet-PEG8-Maleimide | SC-8805 | C36H53N7O12 |
| Me-Tet-PEG4-Maleimide | SC-8804 | C28H37N7O8 |
| Me-Tet-PEG3-Maleimide | SC-8803 | C26H33N7O7 |
| Me-Tet-PEG8-NH2 - HCl salt | SC-8802 | C29H48N6O9 + HCl |
| Me-Tet-PEG4-NH2 | SC-8801 | C21H32N6O5 |
| Me-Tet-PEG3-NH2 | SC-8800 | C19H28N6O4 |
| Biotin-PEG8-Alkyne | SC-8617 | C29H51N3O10S |
| Biotin-PEG4-Alkyne | SC-8616 | C21H35N3O6S |
| Biotin-PEG3-Alkyne | SC-8615 | C19H31N3O5S |
| Biotin-PEG7-N3 | SC-8614 | C26H48N6O9S |
| Biotin-PEG3-N3 | SC-8613 | C18H32N6O5S |
| Biotin-PEG2-N3 | SC-8612 | C16H28N6O4S |
| Biotin-PEG8-COOH | SC-8611 | C29H53N3O12S |
| Biotin-PEG4-COOH | SC-8610 | C19H33N3O7S |
| Biotin-PEG3-COOH | SC-8609 | C19H33N3O7S |
| Biotin-PEG8-NHS | SC-8608 | C33H56N4O14S |
| Biotin-PEG4-NHS | SC-8607 | C25H40N4O10S |
| Biotin-PEG3-NHS | SC-8606 | C23H36N4O9S |
| Biotin-PEG7-Maleimide | SC-8605 | C33H55N5O12S |
| Biotin-PEG3-Maleimide | SC-8604 | C25H39N5O8S |
| Biotin-PEG2-Maleimide | SC-8603 | C23H35N5O7S |
| Biotin-PEG7-NH2 | SC-8602 | C26H50N4O9S |
| Biotin-PEG3-NH2 | SC-8601 | C18H34N4O5S |
| Biotin-PEG2-NH2 | SC-8600 | C16H30N4O4S |
| TCO4-PEG8-COOH | SC-8411 | C28H51NO12 |
| TCO*-PEG8-COOH | SC-8511 | C28H51NO12 |
| TCO*-PEG4-COOH | SC-8510 | C20H35NO8 |
| TCO4-PEG4-COOH | SC-8410 | C20H35NO8 |
| TCO4-PEG3-COOH | SC-8409 | C18H31NO7 |
| TCO*-PEG3-COOH | SC-8509 | C20H31NO7 |
| TCO*-PEG8-NHS | SC-8508 | C32H54N2O14 |
| TCO4-PEG8-NHS | SC-8408 | C32H54N2O14 |
| TCO4-PEG4-NHS | SC-8407 | C24H38N2O10 |
| TCO*-PEG4-NHS | SC-8507 | C24H38N2O10 |
| TCO*-PEG3-NHS | SC-8506 | C22H34N2O9 |
| TCO4-PEG3-NHS | SC-8406 | C22H34N2O9 |
| TCO*-PEG7-Maleimide | SC-8505 | C32H53N3O12 |
| TCO*-PEG3-Maleimide | SC-8504 | C24H37N3O8 |
| TCO*-PEG2-Maleimide | SC-8503 | C22H33N3O7 |
| TCO4-PEG7-Maleimide | SC-8405 | C32H53N3O12 |
| TCO4-PEG3-Maleimide | SC-8404 | C24H37N3O8 |
| TCO4-PEG2-Maleimide | SC-8403 | C22H33N3O7 |
| TCO*-PEG2-NH2 | SC-8500 | C15H28N2O4 |
| TCO*-PEG3-NH2 | SC-8501 | C17H32N2O5 |
| TCO*-PEG7-NH2 | SC-8502 | C25H48N2O9 |
| TCO4-PEG7-NH2 | SC-8402 | C25H48N2O9 |
| TCO4-PEG3-NH2 | SC-8401 | C17H32N2O5 |
| TCO4-PEG2-NH2 | SC-8400 | C15H28N2O4 |
| SCO-PEG7-Maleimide | SC-8305 | C32H51N3O12 |
| SCO-PEG3-Maleimide | SC-8304 | C24H35N3O8 |
| SCO-PEG2-Maleimide | SC-8303 | C22H31N3O7 |
| BCN-exo-PEG7-Maleimide | SC-8205 | C34H53N3O12 |
| BCN-exo-PEG3-Maleimide | SC-8204 | C24H33N3O7 |
| BCN-exo-PEG2-Maleimide | SC-8203 | C24H33N3O7 |
| BCN-endo-PEG7-Maleimide | SC-8105 | C34H53N3O12 |
| BCN-endo-PEG3-Maleimide | SC-8104 | C24H33N3O7 |
| BCN-endo-PEG2-Maleimide | SC-8103 | C24H33N3O7 |
| BCN-exo-PEG8-COOH | SC-8211 | C30H51NO12 |
| BCN-exo-PEG4-COOH | SC-8210 | C22H35NO8 |
| BCN-exo-PEG3-COOH | SC-8209 | C20H31NO7 |
| BCN-exo-PEG8-NHS | SC-8208 | C34H54N2O14 |
| BCN-exo-PEG4-NHS | SC-8207 | C26H38N2O10 |
| BCN-exo-PEG3-NHS | SC-8206 | C24H34N2O9 |
| BCN-endo-PEG3-NHS | SC-8106 | C24H34N2O9 |
| BCN-endo-PEG4-NHS | SC-8107 | C26H38N2O10 |
| BCN-endo-PEG8-NHS | SC-8108 | C34H54N2O14 |
| BCN-endo-PEG8-COOH | SC-8111 | C30H51NO12 |
| BCN-endo-PEG4-COOH | SC-8110 | C22H35NO8 |
| BCN-endo-PEG3-COOH | SC-8109 | C20H31NO7 |
| SCO-PEG3-COOH | SC-8309 | C18H29NO7 |
| SCO-PEG4-COOH | SC-8310 | C20H33NO8 |
| SCO-PEG8-COOH | SC-8311 | C28H49NO12 |
| SCO-PEG8-NHS | SC-8308 | C32H52N2O14 |
| SCO-PEG4-NHS | SC-8307 | C24H36N2O10 |
| SCO-PEG3-NHS | SC-8306 | C22H32N2O9 |
| SCO-PEG7-NH2 | SC-8302 | C25H46N2O9 |
| SCO-PEG3-NH2 | SC-8301 | C17H30N2O5 |
| SCO-PEG2-NH2 | SC-8300 | C15H26N2O4 |
| BCN-exo-PEG2-NH2 | SC-8200 | C17H28N2O4 |
| BCN-exo-PEG3-NH2 | SC-8201 | C19H32N2O5 |
| BCN-exo-PEG7-NH2 | SC-8202 | C27H48N2O9 |
| BCN-endo-PEG7-NH2 | SC-8102 | C27H48N2O9 |
| BCN-endo-PEG3-NH2 | SC-8101 | C19H32N2O5 |
| BCN-endo-PEG2-NH2 | SC-8100 | C17H28N2O4 |
| PEG-12 | SC-1512 | C24H50O13 |
| PEG-11 | SC-1511 | C22H46O12 |
| PEG-10 | SC-1510 | C20H42O11 |
| PEG-9 | SC-1509 | C18H38O10 |
| PEG-8 | SC-1508 | C16H34O9 |
| Alkyne - PEG2 - TCA | SC-0067 | C9H12Cl3NO3 |
| Azido - PEG2 - TCA | SC-0066 | C6H9Cl3N4O2 |
| Alkyne - PEG2 - CM | SC-0065 | C8H13ClO3 |
| Azido - PEG2 - CM | SC-0064 | C5H10ClN3O |
| Alkyne - PEG2 | SC-0063 | C7H12O3 |
| Azido - PEG1 | SC-0062 | C4H9N3O2 |
| 2-Methyl-Glycerol | SC-0006 | C4H10O3 |
| 2-Stearoyl glycerol | SC-1171 | C21H42O4 |
| 2-Palmitoyl glycerol | SC-1170 | C19H38O4 |
| 2-Myristoyl glycerol | SC-1169 | C17H34O4 |
| 2-Lauroyl glycerol | SC-1168 | C15H30O4 |
| 2-Linoleoyl glycerol | SC-1167 | C21H38O4 |
| 2-Oleoyl-glycerol | SC-1162 | C21H40O4 |
| SH-6 | SC-0045 | C28H57O9P |
| SH-5 | SC-0044 | C29H59O10P |
| Ins(345)P3*3Na | 3-0-345-Na | C6H12Na3O15P3 |
| Ins(1)P*2K | 1-0-1-2K | C6H11K2O9P |
| myo-Inositol – trispyrophosphate | Pyro-Ins-Na | C6H8Na4O21P6 |
| Ins(123456)P6 | 6-0-123456-Na | C6H18O24P6 * xNa*yH2O |
| Ins(23456)P5*10Na | 5-0-23456-Na | C6H7Na10O21P5 |
| Ins(13456)P5*10Na | 5-0-13456-Na | C6H7Na10O21P5 |
| Ins(12456)P5*10Na | 5-0-12456-Na | C6H7Na10O21P5 |
| Ins(12356)P5*10Na | 5-0-12356-Na | C6H7Na10O21P5 |
| Ins(12345)P5*10Na | 5-0-12345-Na | C6H7Na10O21P5 |
| Ins(1345)P4*8Na | 4-0-1345-Na | C6H8Na8O18P4 |
| Ins(136)P3*6Na | 3-0-136-Na | C6H9Na6O15P3 |
| Ins(134)P3*6K | 3-0-134-K | C6H9K6O15P3 |
| Ins(345)P3*3K | 3-0-345-K | C6H12K3O15P3 |
| Ins(145)P3*6K | 3-0-145-K | C6H9K6O15P3 |
| Ins(145)P3*3Li | 3-0-145-Li | C6H12Li3O15P3 |
| Ins(145)P3*6Na | 3-0-145-Na | C6H9Na6O15P3 |
| Ins(135)P3*6Na | 3-0-135-6Na | C6H9Na6O15P3 |
| Ins(1245)P4*8Na | 4-0-1245-Na | C6H8Na8O18P4 |
| INO-4995 | INO-4995 | C50H86O35P4 |
| Bt3-Ins(356)P3 / PM | 3-2-356 | C42H69O30P3 |
| Bt3-Ins(346)P3 / PM | 3-2-346 | C42H69O30P3 |
| Bt3-Ins(146)P3 / PM | 3-2-146 | C42H69O30P3 |
| Bt3-Ins(135)P3 / PM | 3-2-135 | C42H69O30P3 |
| caged-Ins(145)P3 / PM | cag-iso-2-145-10 | C42H64NO31P3 |
| caged-Ins(145)P3 / PM | cag-iso-2-145-100 | C42H64NO31P3 |
| Bt2-Ins(3456)P4 / PM | 4-2-3456 | C46H76O36P4 |
| Bt2-Ins(1456)P4 / PM | 4-2-1456 | C46H76O36P4 |
| Bt2-Ins(1345)P4 / PM | 4-2-1345 | C46H76O36P4 |
| Bt2-Ins(1356)P4 / AM | 4-1-1356 | C38H60O36P4 |
| Bt3-Ins(356)P3 / AM | 3-1-356 | C36H57O30P3 |
| Bt3-Ins(346)P3 / AM | 3-1-346 | C36H57O30P3 |
| Bt3-Ins(146)P3 / AM | 3-1-146 | C36H57O30P3 |
| Bt3-Ins(134)P3 / AM | 3-1-134 | C36H57O30P3 |
| Bt3-Ins(136)P3 / AM | 3-1-136 | C36H57O30P3 |
| Bt3-Ins(135)P3 / AM | 3-1-135 | C36H57O30P3 |
| Bt3-Ins(145)P3 / AM | 3-1-145 | C36H57O30P3 |
| caged-Ins(145)P3 / PM | cag-iso-2-145-10 | C42H64NO31P3 |
| caged-Ins(145)P3 / PM | cag-iso-2-145-100 | C42H64NO31P3 |
| caged-Ins(145)P3O6 | cag-6-145 | C15H18NO19P3Na6 |
| caged-Ins(145)P3 P4 | cag-0-145 | C14H19NO17P3Na3 |
| PtdIns(345)P3 | Ptd-0-345-16 | C41H82O22P4 |
| PtdIns(45)P2 | Ptd-0-45-16 | C41H81O19P3 |
| PtdIns(34)P2 | Ptd-0-34-16 | C41H81O19P3 |
| PtdIns(5)P | Ptd-0-5-16 | C41H80O16P2 |
| PtdIns(4)P | Ptd-0-4-16 | C41H80O16P2 |
| PtdIns(3)P | Ptd-0-3-16 | C41H80O16P2 |
| PtdIns(1)P | Ptd-0-1-16 | C41H79O13P |
| D-myo-Inositol-1,2-O-cyclohexylidene | SC-0088 | C12H20O6 |
| 23:45- diisopropylidene-myo-Inositol | SC-0079 | C12H20O6 |
| 12:56- diisopropylidene-myo-Inositol | SC-0078 | C12H20O6 |
| D-myo-Inositol-2,3-O-cyclohexylidene | SC-0077 | C12H20O6 |
| 1,4-Di-butyryl-23:56-diisopropylidene-myo-Inositol | SC-0076 | C20H32O8 |
| 3,6-Di-butyryl-12:45-diisopropylidene-myo-Inositol | SC-0075 | C20H32O8 |
| 2,3:4,5-Di-O-Iso-1,6-Di-O-Benzyl-Ins | IOB-Ins-2345 | C26H32O6 |
| 1,2:5,6-Di-O-Iso-3,4-Di-O-Benzyl-Ins | IOB-Ins-1256 | C26H32O6 |
| 3,4,5,6-Tetra-O-Benzyl-Ins | TOB-Ins-3456 | C34H36O6 |
| 1,4,5,6-Tetra-O-Benzyl-Ins | TOB-Ins-1456 | C34H36O6 |
| DEAC-dUTP | SC-9002 | C26H31N4O17P3 |
| 35-PAPS-TEA | SC-9000-TEA | C10H15N5O13P2S x 4 C6 H15 N |
| ACPPS-TEA | SC-0068 | C10H13N5O12P2S + C6H5N |
| 25-PAPS-Li | SC-9001-Li | C10H11Li4N5O13P2S |
| 35-PAPS-Li (CAS: 102029-54-9) | SC-9000-Li | C10H11Li4N5O13P2S |
| EdU | SC-0040 | C11H12N2O5 |
| EdUTP-TEA | SC-0039 | C11H15N2O14P3 * 4(C6H15N) |
| EdUTP | SC-0038 | C11H15N2O14P3 |
| 2'-PAP | SC-0037 | C10H17N5O10P2 |
| 2'-PAP-Na | SC-0036 | C10H15N5Na2O10P2 |
| 3'-PAP-Na | SC-0034 | C10H15N5Na2O10P2 |
| 3'-PAP | SC-0035 | C10H17N5O10P2 |
| Vancomycin hexapeptide | SC-1606 | C59H62Cl2N8O23 |
| Didechloro Vancomycin | SC-1605 | C66H77N9O24 |
| Vancomycin Impurity A | SC-1601 | C65H73Cl2N9O24 |
| Vancomycin Impurity D | SC-1604 | C59H62Cl2N8O22 |
| Vancomycin Impurity C | SC-1603 | C53H52Cl2N8O17 |
| Vancomycin Impurity B | SC-1602 | C66H74Cl2N8O25 |
| INO-4995 | INO-4995 | C50H86O35P4 |
| Fidaxomicin - d7 | SC-1157 | C52H67D7Cl2O18 |
| Podophyllotoxin Derivate | SC-0025 | C21H20O8 |
| Podophyllotoxin Derivate | SC-0026 | C21H21NO7 |
| Clopidogrel Impurity 4 | SC-0099 | C16H16ClNO2S * H2SO4 |
| Gestodene Impurity E | SC-0028 | C21H24O3 |
| Fidaxomicin Metabolite OP-1118 | SC-1158 | C48H68Cl2O17 |
| Prasugrel metabolite M6-d3 (stabilzed) | SC-0093 | C27H25D3FNO5S * HCl |
| Prasugrel metabolite M6 | SC-0092 | C19H22FNO3S |
| Clopidogrel Impurity C | SC-0087 | C16H18ClNO2S |
| Clopidogrel Impurity 3 | SC-0086 | C15H17Cl2NO2S |
| Prasugrel active metabolite M3-d3 (stabilzed) | SC-0033 | C27H25D3FNO5S * HCl |
| Prasugrel active metabolite M3 HCl (stabilized) | SC-0029 | C27H28FNO5S * HCl |
| Fidaxomicin - d7 | SC-1157 | C52H67D7Cl2O18 |
| Methyl 4-(2-hydroxyethyl)benzoate-13C6,2D (Ring-13C6,Ethyl-1,2-D2) | SC-0080 | C4 13C6 H10 D2 O3 |
| Anthracene 13C6 | SC-0074 | 13C6C8H8 |
| Phenanthrene 13C6 | SC-0073 | 13C6C8H8 |
| Naphthalene 13C10 | SC-0072 | 13C10H8 |
| Naphthalene 13C6 | SC-0071 | 13C6C4H8 |
| Prasugrel active metabolite M3-d3 (stabilzed) | SC-0033 | C27H25D3FNO5S * HCl |
| 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite | SC-0091 | C9H18ClN2OP |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(2-cyanoethyl) ester | SC-0061 | C12H22N3O2P |
| Phosphoramidous acid, N,N-bis(1-methylethyl)-, bis(phenylmethyl) ester | SC-1165 | C20 H28 N O2 P |
| Phosphorodiamidous acid. N.N.N'.N'-tetrakis(1-methylethyl)-. phenylmethyl ester | SC-0060 | C19 H35 N2 O P |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. 2-cyanoethyl [1-(2-nitrophenyl)ethyl] ester) | SC-0059 | C17 H26 N3 O4 P |
| Dichloro N,N-Diisopropylphosphoramidite | SC-0058 | C6 H14 Cl2 N P |
| Phosphoramidous acid. N.N-bis(1-methylethyl)-. bis(9H-fluoren-9-ylmethyl) ester | SC-0057 | C34 H36 N O2 P |
| Di-tert-butyl chloromethyl phosphate | SC-0011 | C9H20ClO4P |
| Di-benzyl chloromethyl phosphate | SC-0010 | C15H16ClO4P |
| TMe-OHB-DAZA | SC-0300 | C29H37N3O6 |
| TEt-OHB-DAZA | SC-0301 | C32H43N3O6 |
| NEmo2E | SC-0201 | C96H138KN18O30S |
| NEmo1 | SC-0200 | C96H138KN18O30S |
| D-Serine-O-phosphate | SC-1810 | C3H8NO6P |
| Ph-CCA-NH2 | SC-1400 | C16H12N2O |
| Menaquinone 8 / MK 8:8 | SC-1230 | C51H72O2 |
| Allyl-Maleimide | SC-1121 | C7H7NO2 |
| Nor-cisapride Derivative | SC-1161 | C17H25Cl2N3O3 |
| AlK - L - Lysine - HCl-salt | SC-8012 | C10H18N2O4* HCl |
| 4-methyl-2,2-bis(trifluoromethyl)oxazolidin-5-one | SC-0098 | C6H5F6NO2 |
| 3-(5-oxo-2,2-bis(trifluoromethyl)oxazolidin-4-yl)propanoic acid | SC-0097 | C8H7F6NO4 |
| 7-(diethylamino)-4-(hydroxymethyl)-coumarin / DEACM | SC-0096 | C14H17NO3 |
| 3-bromo-4-methyl-7-(diethylamino)-coumarin | SC-0095 | C14H16BrNO2 |
| Xanthohumol | SC-0094 | C21H22O5 |
| IEPOX 4 | SC-0090 | C5H10O3 |
| IEPOX 3 | SC-0089 | C5H10O3 |
| 2-C-Methyl-L-Threitol | SC-0085 | C5H12O4 |
| 2-C-Methyl-D-Threitol | SC-0084 | C5H12O4 |
| 2-C-Methyl-L-Erythritol | SC-0083 | C5H12O4 |
| 2-C-Methyl-D-Erythritol | SC-0082 | C5H12O4 |
| 3-Amino-7-(diethylamino)-coumarine | SC-0081 | C13 H16 N2 O2 |
| Chloromethylpropionate | SC-1164 | C4H7ClO2 |
| 2-(2-fluoro-2-methylpropoxy)-2-methylpropan-1-ol | SC-1163 | C8H17FO2 |
| 1,4-Di-butyryl-23:56-diisopropylidene-myo-Inositol | SC-0076 | C20H32O8 |
| 3,6-Di-butyryl-12:45-diisopropylidene-myo-Inositol | SC-0075 | C20H32O8 |
| Y-27632 | SC-0048 | C14H21N3O *2HCl |
| H-1152 | SC-0053 | C16H21N3O2S*2HCl |
| 3,4,5,6-Tetra-O-Benzyl-Ins | TOB-Ins-3456 | C34H36O6 |
| 1,4,5,6-Tetra-O-Benzyl-Ins | TOB-Ins-1456 | C34H36O6 |
| Biotin-PEG3-CoenzymeA | SC-8618 | C46H75N12O24P3S2+3NH3 |
| TMe-OHB-DAZA | SC-0300 | C29H37N3O6 |
| TEt-OHB-DAZA | SC-0301 | C32H43N3O6 |
| SCO-NHS carbonate | SC-8076 | C13H15NO5 |
| endo-BCN-NHS carbonate | SC-8074 | C15H17NO5 |
| TCO4 - NHS carbonate / EQUATORIAL isomer | SC-8073 | C13H17NO5 |
| TCO4 - NHS carbonate / AXIAL isomer | SC-8072 | C13H17NO5 |
| TCO* - NHS carbonate / EQUATORIAL isomer | SC-8071 | C13H17NO5 |
| TCO* - NHS carbonate / AXIAL isomer | SC-8070 | C13H17NO5 |
| NEmo2E | SC-0201 | C96H138KN18O30S |
| NEmo1 | SC-0200 | C96H138KN18O30S |
| bifunctional Cross-Linking-Amino-Acid / PrDiAzK | SC-8028 | C13H20N4O5 |
| Vancomycin hexapeptide | SC-1606 | C59H62Cl2N8O23 |
| Ph-CCA-NH2 | SC-1400 | C16H12N2O |
| Cross-Linking-Amino-Acid / DiAzK | SC-8034 | C11H20N4O4 |
| PEG-9 | SC-1509 | C18H38O10 |
| PEG-8 | SC-1508 | C16H34O9 |
| Click Amino Acid / cyclopropene – L - Lysine (CP) | SC-8017 | C12H20N2O4 |
<艾美捷科技代理Protide Pharmaceuticals品牌全系列产品
Protide Pharmaceuticals, Inc.是一家专注于生物制药生产上游工艺的创新型公司。Protide Pharmaceuticals公司的核心产品为血清替代物，其核心价值在于提供高性能、化学成分明确、无动物来源的血清替代物和定制化培养基解决方案，帮助客户大幅减少生物制品生产过程中对胎牛血清或其他动物血清的依赖。，从而提高生物制品生产的效率、一致性、安全性和合规性。
除了血清替代物，Protide Pharmaceuticals公司也提供完整的、优化的无血清培养基配方，专门设计用于支持各种哺乳动物细胞系（如CHO, HEK293, Vero, MRC-5等）在生物反应器中进行高密度培养和高产率生产目标生物分子（如抗体、病毒载体、重组蛋白）。其产品应用于再生医学、肿瘤生物学、细胞生物能量学、肿瘤免疫学、转化医学、表观遗传学，胰岛细胞移植等领域。
▎Protide Pharmaceuticals产品线
● 血清替代品/生物制品生产培养基
Protide Pharmaceuticals的血清替代品通过提供优质、生物一致且功能性的环境，显著改善细胞的生理状态。所有血清替代品均配制成 50 倍浓缩液，这大大降低了成本，并改善了储存和供应链活动。Protide血清替代品不含：酚红、生长因子、类固醇激素、糖皮质激素、细胞粘附分子、生长因子、类固醇激素等物质，可以在其缺失或存在的情况下进行有效研究。细胞分泌的蛋白质可以在不受污染性血清成分干扰的情况下实现高度纯化。
| 品名 | 货号-规格 | 产品描述 |
| TCH™ | 3001-40ml；3002-100ml；3005-100ml | 本血清替代品主要用于人类细胞培养及细胞分泌蛋白的生产。TCH™ 在培养其他哺乳动物细胞时同样有效，且不含动物蛋白。其成分仅包含经热处理的人源蛋白（即人血清白蛋白、人转铁蛋白、重组人胰岛素）。 |
| VaxMax™ | 6004-100ml；6005-500ml；6006-1L | 100倍浓缩液是一种高性价比产品，可显著降低总体血清需求量。在MDBK、MDCK、Vero、CRFK及猪睾丸细胞培养中，使用VaxMax™已展现出显著的产量提升。兽用疫苗生产商已采用VaxMax™来增强生产，同时降低总体成本。VaxMax™通常与0.5%至1% 的血清配合使用。 |
| HemaPro™ | 3300-40ml；3303-100ml | 本产品为无血清添加剂，专为人祖细胞培养而设计。可有效用于癌症干细胞、诱导多能干细胞和间充质干细胞 的研究。不含：促红细胞生成素；重组生长因子。 |
| TM-235™ | 2001-40ml；2002-100ml；2005-500ml | 本血清替代品具有与TCM™类似的特性，但额外添加了适用于需要更高血清浓度（通常超过10%）的细胞类型的成分。TM-235™是一种成分明确且多用途的替代品。 |
| TCM™ | 1001-40ml；1002-100ml；1005-500ml | 本产品是一种通用型血清替代品，适用于多种物种来源的广泛细胞类型。TCM™是一种成分明确且多用途的血清替代品，可有效用于研究生长因子的影响以及蛋白质的生产。 |
● 低温保护剂
| 品名 | 货号-规格 | 产品描述 |
| Stemsol™ USP (DMSO) | PP1250-5ml；PP1300-10ml；PP1350-50ml；PP1400-100ml | 本产品为干细胞冻存溶液，适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。 |
| pZerve™ | 5700-60ml;5720-20ml | pZerve™ 是一款独特的冻存溶液，不含 DMSO、胎牛血清或动物蛋白。本品为即用型，无需任何稀释或进一步处理。适用细胞类型包括：肥大细胞、树突细胞、间充质细胞、人转移性前列腺腺癌细胞、人结肠腺癌细胞，人转化胚肾细胞。 |
| Cellvation™ | 5001-60ml | Cellvation™ 是一款独特的冻存溶液，不含 DMSO 或胎牛血清。本品使用便捷，并能提供最佳的细胞复苏效果。在冷冻程序启动前，细胞可置于 Cellvation™ 中较长时间。本品为即用型，适用于无血清培养基或含血清培养基培养的细胞。 |
| MiCord™ 55% DMSO USP 5% Dextran USP | 1505-5ml;1500-7ml;;1700-10ml;1550-50ml;1600-100ml | 本产品为干细胞冻存溶液，适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。 |
| 2-8CELLsius™ + DMSO，5% DMSO | PP338DM5-10ml;PP338DM5-100ml;PP338DM5-100B | 当与DMSO配合使用时，2-8CELLsius™可用作冻存液。2-8CELLsius™ + DMSO冻存液是一种细胞保护性、无蛋白溶液，含有生物稳定剂，可支持冻融后细胞的高存活率。其通过针对超低温下细胞生理学的创新方法，实现最佳的细胞复苏效果。不含：任何生长因子，激素以及抗生素。 |
| 2-8CELLsius™ + DMSO，10% DMSO | PP338DM10-10ml;PP338DM10-100ml；PP338DM10-100B；PP338DM10-1000B | |
| 2-8CELLsius™ + DMSO，20% DMSO | PP338DM20-100B；PP338DM20-1000B |
● 细胞处理
| 品名 | 货号-规格 | 产品描述 |
| 2-8CELLsius™ | PP338-100ml；PP338-500ml；PP338-1000；PP338-1000B | 即用型、平衡、细胞保护性、无蛋白溶液，含生物稳定剂，适用于：短期储存、再生医学、干细胞处理以及生物材料运输。 |
| Dextran 40 in 0.9% NaCl | PP1850-50ml;PP1840-1000ml;PP1880-250ml;PP1900-500ml | - |
| Dulbecco’s Phosphate Buffered Saline (10X) PBS | PBS210-500ml;PBS211-1000ml | 无钙镁储存条件：15-30°C；包装于PETG瓶；稳定性：至少6个月；无菌过滤 |
| Dulbecco’s Phosphate Buffered Saline (1X) PBS | PBS200-500ml;PBS201-1000ml | 无钙镁储存条件：15-30°C；包装于PETG瓶；稳定性：至少6个月；无菌过滤 |
| Hank’s Balanced Salt Solution (1X) HBSS | HS240-500ml;HS241-1000ml | 无钙镁配方：储存温度 4-8°C；无酚红配方；稳定性：至少6个月；含0.35克/升 碳酸氢钠；含1000毫克/升 D-葡萄糖；包装于 PETG 瓶，无菌过滤。cGMP 规范生产。 |
● CIT 胰岛细胞溶液
| 品名 | 货号-规格 |
| Cold Storage/Purification Stock Solution | 111098-1L |
| Phase I Solution | 060899-1L |
<艾美捷科技有限公司代理Echelon Biosciences的产品：
http://www.amyjet.com/Index/lists/catid/27/kid/57.html
Echelon Biosciences成立于1997年，致力于为脂质研究领域提供高品质的检测方法和检测试剂。
Echelon Biosciences Incorporated (EBI) was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. Initially, EBI was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, with the aim to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.
Echelon Bioscience的产品和服务包括：
| (2S)-Oleyl LPA (Echelon Bioscience, CAT#L-0186) |
| (E,E,E)-Geranylgeraniol (Echelon Bioscience, CAT#S-0200) |
| (E,E)-Farnesoic acid (Echelon Bioscience, CAT#S-0151) |
| (E,E)-Methyl Farnesoate (Echelon Bioscience, CAT#S-0153) |
| (S,S) Bisoleoyl-lysobisphosphatidic acid (LBPA) (Echelon Bioscience, CAT#L-B181) |
| (S)-FTY720 Phosphate (Echelon Bioscience, CAT#B-0721) |
| [4-(Decanoylamino)benzyl]phosphonic acid (GWJ-23, GWJ-A-23) (Echelon Bioscience, CAT#L-3223) |
| [D-Ala2]-Deltorphin II (Echelon Bioscience, CAT#275-21) |
| [Hyp3]-Bradykinin (Echelon Bioscience, CAT#191-65) |
| [Ser25] Protein Kinase C Substrate (19-31) (Echelon Bioscience, CAT#871-21) |
| 1-Deoxy-D-xylulose (DX) (Echelon Bioscience, CAT#I-M050A) |
| 1-Deoxy-D-xylulose 5-phosphate (DXP) (Echelon Bioscience, CAT#I-M050) |
| 1-Hydroxy-2-methyl-2-buten-4-yl 4-diphosphate (HDMAPP) (Echelon Bioscience, CAT#I-M055) |
| 1-Methylhistamine dihydrochloride (Echelon Bioscience, CAT#B-0032) |
| 1-Naphthalenesulfonyl-Ile-Trp-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-76) |
| 1-Stearoyl-2-Arachidonoyl-sn-Glycerol (Echelon Bioscience, CAT#L-0024) |
| 1,2-Distearoyl-sn-glycerol (Echelon Bioscience, CAT#L-0018) |
| 1,3-DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2216) |
| 1,3-POPE (16:0/18:1 PE) (Echelon Bioscience, CAT#L-2368) |
| 16:0 LPE (Echelon Bioscience, CAT#L-2516) |
| 16:0 LPG (Echelon Bioscience, CAT#L-5216) |
| 16:0 LPThr (Echelon Bioscience, CAT#L-3316) |
| 18:1 LysoPEth (Echelon Bioscience, CAT#L-6030) |
| 18:2 LysoPC (Echelon Bioscience, CAT#L-1520) |
| 1D-O-(1,2-Di-O-oleoyl-sn-(2S)-glycerol-3-phospho)-3-(phosphothionate)-myo-inositol (Echelon Bioscience, CAT#P-3S18) |
| 1R,2R-B13 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0042) |
| 2-Acetyl-5-tetrahydroxybutyl imidazole (THI) (Echelon Bioscience, CAT#B-0031) |
| 2-C-Methyl-D-erythritol 2,4-cyclophosphate (Echelon Bioscience, CAT#I-M054) |
| 2-C-Methyl-D-erythritol 4-phosphate (MEP) (Echelon Bioscience, CAT#I-M051) |
| 2-C-Methyl-erythritol (ME) (Echelon Bioscience, CAT#I-M051A) |
| 2-Furoyl-LIGR-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-12) |
| 2-Furoyl-LIGRL-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-11) |
| 2-Furoyl-LIGRLO-NH2 (Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-10) |
| 2-O-Butyryl-Ins(1,3,4,5,6)P5/PM (Echelon Bioscience, CAT#Q-M1396) |
| 2,3-Oxidosqualene (racemic) (Echelon Bioscience, CAT#S-0301) |
| 2,3,22,23-Dioxidosqualene (Echelon Bioscience, CAT#S-0302) |
| 2,3,5-Tri-O-butyryl-Ins(1,4,6)P3/AM (Echelon Bioscience, CAT#Q-M0146) |
| 2S-OMPT (Echelon Bioscience, CAT#L-9418) |
| 2Z,6Z-Farnesol (Echelon Bioscience, CAT#S-0170) |
| 2Z,6Z-Farnesyl Diphosphate (Echelon Bioscience, CAT#I-0170) |
| 3-a-Aminocholestane (3AC, SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0341) |
| 3,3′-Bisoleoyl-LBPA tetrabutylammonium salt (Echelon Bioscience, CAT#L-B182) |
| 3C-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3C916) |
| 3C-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3C908) |
| 3S-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3S916) |
| 3S-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3S908) |
| 4-Demethylaminosancycline (CMT-3) (Echelon Bioscience, CAT#B-0802) |
| 4-Diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) (Echelon Bioscience, CAT#I-M052) |
| 4-Methylumbelliferone (Echelon Bioscience, CAT#JK201388) |
| 5-Ketoclomazone (DXP Synthase Inhibitor) (Echelon Bioscience, CAT#B-4101) |
| 5′ PtdIns(3,4,5)P3 Phosphatase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1400) |
| 6-O-palmitoyl-L-ascorbic acid (HAse Inhibitor) (Echelon Bioscience, CAT#B-0601) |
| 7-azido-4-methylcoumarin (AzMC, Hydrogen sulfide detector) (Echelon Bioscience, CAT#D-0010) |
| 9-tert-Butyl Doxycycline HCl (Echelon Bioscience, CAT#B-0801) |
| 9(10)-Nitrooleic Acid (Echelon Bioscience, CAT#L-0112) |
| 9Z-Octadecenyl phosphate (Echelon Bioscience, CAT#L-0418) |
| a-Secretase Substrate (Echelon Bioscience, CAT#640-55) |
| ABC294640 (SPHK2 Inhibitor) (Echelon Bioscience, CAT#B-0025) |
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide (Metalloendopeptidase Substrate) (Echelon Bioscience, CAT#855-46) |
| Ac-Ala-Arg-AMC (Echelon Bioscience, CAT#877-13) |
| Ac-Ala-Glu-Val-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-65) |
| Ac-Ala-Glu-Val-Asp-CHO (Caspase 3 Inhibitor) (Echelon Bioscience, CAT#864-65) |
| Ac-Ala-Glu-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-65) |
| Ac-Arg-Ala-Arg-AMC (Echelon Bioscience, CAT#855-71) |
| Ac-Arg-Ala-Val-AMC (Echelon Bioscience, CAT#877-08) |
| Ac-Arg-Gly-Phe-Phe-Pro-AFC (Cathepsin D Substrate, fluorogenic) (Echelon Bioscience, CAT#874-19) |
| Ac-Arg-Gly-Phe-Phe-Pro-AMC (Echelon Bioscience, CAT#877-06) |
| Ac-Arg-Leu-Arg-AMC (Echelon Bioscience, CAT#920-75) |
| Ac-Arg-Ser-Leu-Lys-AMC (Site 1 Protease Substrate, fluorogenic) (Echelon Bioscience, CAT#877-09) |
| Ac-Asp-Gln-Met-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-26) |
| Ac-Asp-Gln-Met-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-22) |
| Ac-Asp-Glu-Val-Asp-4MbNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#861-18) |
| Ac-Asp-Glu-Val-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-18) |
| Ac-Asp-Glu-Val-Asp-pNA (Caspase-3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-20) |
| Ac-Asp-Met-Gln-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-30) |
| Ac-Asp-Met-Gln-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-28) |
| Ac-Asp-Met-Gln-Asp-pNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-25) |
| Ac-DEVD-AFC, (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-17) |
| Ac-DEVD-CHO, Caspase 3 (Apopain) Inhibitor (Echelon Bioscience, CAT#864-20) |
| Ac-Glu-Ser-Met-Asp-AFC (Procaspase 3 Substrate, fluorogenic) (Echelon Bioscience, CAT#880-22) |
| Ac-Glu-Ser-Met-Asp-CHO (Procaspase 3 Inhibitor) (Echelon Bioscience, CAT#864-22) |
| Ac-Glu-Val-Asn-Leu-AMC (Echelon Bioscience, CAT#877-11) |
| Ac-Glu-Val-Asn-Leu-pNA (Echelon Bioscience, CAT#876-06) |
| Ac-Ile-Gln-Ala-Cys-Arg-Gly-OH (Caspase Active Site Peptide) (Echelon Bioscience, CAT#866-12) |
| Ac-Ile-Glu-Pro-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-30) |
| Ac-Ile-Glu-Pro-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-69) |
| Ac-Ile-Glu-Pro-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#865-30) |
| Ac-Ile-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-58) |
| Ac-Ile-Glu-Thr-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-58) |
| Ac-Ile-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor / Granzyme B Inhibitor II) (Echelon Bioscience, CAT#860-59) |
| Ac-Ile-Glu-Thr-Asp-pNA (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-56) |
| Ac-Leu-Asp-Glu-Ser-Asp-AMC (Caspase 2/3 Substrate) (Echelon Bioscience, CAT#860-43) |
| Ac-Leu-Glu-Glu-Asp-AFC (Caspase 13 Substrate) (Echelon Bioscience, CAT#863-55) |
| Ac-Leu-Glu-Glu-Asp-AMC (Caspase 13 Substrate) (Echelon Bioscience, CAT#862-55) |
| Ac-Leu-Glu-Glu-Asp-CHO (Caspase 13 Inhibitor) (Echelon Bioscience, CAT#864-85) |
| Ac-Leu-Glu-Glu-Asp-pNA (Caspase 13 Substrate) (Echelon Bioscience, CAT#861-85) |
| Ac-Leu-Glu-His-Asp-AFC (Caspase 9 Substrate) (Echelon Bioscience, CAT#863-40) |
| Ac-Leu-Glu-His-Asp-AMC (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-45) |
| Ac-Leu-Glu-His-Asp-CHO (Caspase 9 Inhibitor) (Echelon Bioscience, CAT#864-45) |
| Ac-Leu-Glu-His-Asp-pNA (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-47) |
| Ac-Leu-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-44) |
| Ac-Leu-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor) (Echelon Bioscience, CAT#864-44) |
| Ac-Leu-Glu-Val-Asp-AFC (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#863-42) |
| Ac-Leu-Glu-Val-Asp-AMC (Caspase 4 Substrate) (Echelon Bioscience, CAT#860-49) |
| Ac-Leu-Glu-Val-Asp-CHO (Caspase 4 (ICH-2) Inhibitor) (Echelon Bioscience, CAT#864-42) |
| Ac-Leu-Glu-Val-Asp-pNA (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#860-42) |
| Ac-Leu-Leu-Arg-AMC (Echelon Bioscience, CAT#877-12) |
| Ac-Leu-Leu-Tyr-AFC (Echelon Bioscience, CAT#875-20) |
| Ac-Leu-Val-Lys-CHO (Cathepsin B Inhibitor II) (Echelon Bioscience, CAT#866-39) |
| Ac-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphthylamide (Echelon Bioscience, CAT#878-02) |
| Ac-Lys-Pro-Arg-AMC (Echelon Bioscience, CAT#877-07) |
| Ac-Orn-Phe-Arg-AMC (Tryptase Substrate, fluorogenic) (Echelon Bioscience, CAT#871-94) |
| Ac-Phe-Ser-Arg-pNA (Echelon Bioscience, CAT#876-01) |
| Ac-Thr-Gln-Thr-Asp-AFC (DRONC Substrate) (Echelon Bioscience, CAT#850-16) |
| Ac-Thr-Gln-Thr-Glu-AFC (DRONC Substrate I) (Echelon Bioscience, CAT#850-17) |
| Ac-Trp-Glu-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-61) |
| Ac-Trp-Glu-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-63) |
| Ac-Trp-Glu-His-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#863-63) |
| Ac-Trp-Glu-His-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-60) |
| Ac-Trp-Glu-His-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-66) |
| Ac-Trp-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-64) |
| Ac-Trp-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-66) |
| Ac-Tyr-Glu-Val-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-41) |
| Ac-Tyr-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-17) |
| Ac-Tyr-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-16) |
| Ac-Tyr-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-15) |
| Ac-Val-Ala-Asp-4MbNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#863-12) |
| Ac-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-12) |
| Ac-Val-Ala-Asp-CHO (Caspase 1 (ICE) Inhibitor) (Echelon Bioscience, CAT#864-12) |
| Ac-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-11) |
| Ac-Val-Asn-Leu-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-70) |
| Ac-Val-Asp-Gln-Gln-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-44) |
| Ac-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-48) |
| Ac-Val-Asp-Val-Ala-Asp-AMC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-48) |
| Ac-Val-Asp-Val-Ala-Asp-CHO (Caspase 2 (ICH-1) Inhibitor) (Echelon Bioscience, CAT#864-46) |
| Ac-Val-Asp-Val-Ala-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-46) |
| Ac-Val-Gln-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-54) |
| Ac-Val-Glu-His-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-74) |
| Ac-Val-Glu-Ile-Asp-AMC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-52) |
| Ac-Val-Glu-Ile-Asp-CHO (Caspase 6 (Mch2) Inhibitor) (Echelon Bioscience, CAT#860-57) |
| Ac-Val-Glu-Ile-Asp-pNA (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-50) |
| Ac-Val-Glu-Thr-Asp-AMC (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-26) |
| Ac-Val-Lys-Met-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-72) |
| Ac-VEID-AFC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#863-52) |
| Ac-YVAD-CHO, Caspase 1 (ICE) Inhibitor (Echelon Bioscience, CAT#864-15) |
| Acetyl Calcitonin, salmon (Echelon Bioscience, CAT#237-36) |
| Acetyl-Beta Amyloid (25-35) (Echelon Bioscience, CAT#641-59) |
| Acetyl-Neurotensin (8-13) (Echelon Bioscience, CAT#631-41) |
| Acid Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-3200) |
| ACTH (1-17), human (Echelon Bioscience, CAT#111-75) |
| ACTH (1-24), human (Echelon Bioscience, CAT#111-36) |
| ACTH (1-39), rat (Echelon Bioscience, CAT#115-10) |
| ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38), human (Echelon Bioscience, CAT#111-45) |
| Activity Dependant Neuroprotective Protein (74-81) (mouse, rat) (Echelon Bioscience, CAT#878-03) |
| ADAM substrate (Echelon Bioscience, CAT#825-15) |
| Adamantaneacetyl-Bradykinin [DArg0,Hyp3,Thi5,8,DPhe7] (Echelon Bioscience, CAT#191-84) |
| Adrenal Secretogranin, bovine (Echelon Bioscience, CAT#313-20) |
| Adrenomedullin (1-50), rat (Echelon Bioscience, CAT#335-75) |
| Adrenomedullin (1-52), human (Echelon Bioscience, CAT#331-80) |
| Adrenomedullin (11-50), rat (Echelon Bioscience, CAT#335-80) |
| Adrenomedullin (22-52), human (Echelon Bioscience, CAT#331-82) |
| Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 (Echelon Bioscience, CAT#429-15) |
| Akt Substrate (Echelon Bioscience, CAT#868-15) |
| Alkyl-OMPT (Echelon Bioscience, CAT#L-9518) |
| Allatostatin B2, cockroach (Echelon Bioscience, CAT#781-20) |
| Alpha MSH [D-Phe7] (Echelon Bioscience, CAT#570-42) |
| Alpha MSH [Nle4,D-Phe7] (Echelon Bioscience, CAT#570-43) |
| Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide (Echelon Bioscience, CAT#571-49) |
| AMARA peptide substrate (Echelon Bioscience, CAT#890-23) |
| Aminocardiolipin (Amino-CL) (Echelon Bioscience, CAT#L-C16A) |
| Amylin (1-37), human, amide (Echelon Bioscience, CAT#641-50) |
| Amyloid Blocker (Echelon Bioscience, CAT#641-81) |
| Amyloid Fragment (Pro18,Asp21) (17-21) (Echelon Bioscience, CAT#641-64) |
| Angiotensin (1-5) (Echelon Bioscience, CAT#131-53) |
| Angiotensin (1-7) (Echelon Bioscience, CAT#131-41) |
| Angiotensin I (1-9), DRVYIHPFH-OH (Echelon Bioscience, CAT#131-55) |
| Angiotensin I (human) (Echelon Bioscience, CAT#131-25) |
| Angiotensin I [Asn1,Val5,Asn9], salmon (Echelon Bioscience, CAT#137-40) |
| Angiotensin I [Asn1,Val5], goosefish (Echelon Bioscience, CAT#137-39) |
| Angiotensin I [Val5,Asn9], bullfrog (Echelon Bioscience, CAT#137-36) |
| Angiotensin II Antipeptide (Echelon Bioscience, CAT#131-64) |
| Angiotensin II-[Sar1] (Echelon Bioscience, CAT#131-65) |
| Angiotensin II, human (Echelon Bioscience, CAT#131-49) |
| Angiotensin III, human / Angiotensin II-[Des Asp1] (Echelon Bioscience, CAT#131-76) |
| Angiotensinogen (1-14) Renin Substrate, porcine (Echelon Bioscience, CAT#131-82) |
| Anti human Vps34 Antibody (Echelon Bioscience, CAT#Z-R016) |
| Anti-hVps34 Antibody for IP (Echelon Bioscience, CAT#Z-R015) |
| Anti-PEth Autologous IgG ELISA (Echelon Bioscience, CAT#K-5000A) |
| Anti-PtdIns(3,4,5)P3 IgM HRP (Echelon Bioscience, CAT#Z-H345) |
| Anti-PtdIns(3,4,5)P3 IgM In Ascities (Echelon Bioscience, CAT#Z-A345) |
| Anti-PtdIns(4,5)P2 IgM In Ascites (Echelon Bioscience, CAT#Z-A045) |
| Anti-Rat F1-ATP Synthase Alpha Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPA) |
| Anti-Rat F1-ATP Synthase Beta Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPB) |
| Antibody Sample Pack (Echelon Bioscience, CAT#Z-P100) |
| AP-811 (NPR-C receptor ligand) (Echelon Bioscience, CAT#492-10) |
| Apamin, bee venom (SS1-11, SS3-15) (Echelon Bioscience, CAT#425-10) |
| APP Beta Secretase Inhibitor (Echelon Bioscience, CAT#649-10) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-22) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-23) |
| Arachidonoyl LPA, 20:4 LPA (Echelon Bioscience, CAT#L-0204) |
| Arachidoyl LPA, 20:0 LPA (Echelon Bioscience, CAT#L-0200) |
| Arg-Gly-Asp-Ser (RGDS) (Echelon Bioscience, CAT#450-29) |
| ARN14988 (aCDase Inhibitor) (Echelon Bioscience, CAT#B-0041) |
| AS1938909 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0343) |
| AS1949490 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0342) |
| AS604850 (PI3-K gamma Inhibitor 2) (Echelon Bioscience, CAT#B-0302) |
| AS605240 (PI3-K gamma Inhibitor 1) (Echelon Bioscience, CAT#B-0301) |
| Atrial Natriuretic Peptide (1-28), human / ANP (1-28), human (Echelon Bioscience, CAT#151-25) |
| Atrial Natriuretic Peptide (1-28), rat (Echelon Bioscience, CAT#155-56) |
| Atrial Natriuretic Peptide (4-28), rat / Auriculin B (Echelon Bioscience, CAT#155-62) |
| Atrial Natriuretic Peptide (ANP) (4-24), frog (Echelon Bioscience, CAT#153-15) |
| Atrial Natriuretic Peptide (ANP) Des[18-22] (4-23) amide, rat (Echelon Bioscience, CAT#155-40) |
| Atriopeptin III, rat [ANP (127-150), rat] (Echelon Bioscience, CAT#155-63) |
| ATX Sandwich ELISA Assay Service (Echelon Bioscience, CAT#T-5600) |
| ATX-Red AR-2 (Echelon Bioscience, CAT#L-2010) |
| Autocamptide-2 Related Inhibitoy Peptide (Echelon Bioscience, CAT#891-24) |
| Autocamtide-2 Related Inhibitory Peptide, myristoylated (Echelon Bioscience, CAT#891-26) |
| Autotaxin Activity Assay (Echelon Bioscience, CAT#K-4100) |
| Autotaxin Activity Assay Service (Echelon Bioscience, CAT#T-4100) |
| Autotaxin Enzyme, active (Echelon Bioscience, CAT#E-4000) |
| Autotaxin Inhibitor Screening Assay Service (Echelon Bioscience, CAT#T-4200) |
| Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200) |
| Autotaxin Sandwich ELISA Kit (Echelon Bioscience, CAT#K-5600) |
| BAM (6-22) Bovine Adrenal Medulla Peptide (6-22) (Echelon Bioscience, CAT#313-64) |
| BAM 3200 Bovine Adrenal Medulla Peptide E (Echelon Bioscience, CAT#313-65) |
| Benzo[a]pyrene (Echelon Bioscience, CAT#B-0050) |
| Beta Amyloid (25-35), human (Echelon Bioscience, CAT#641-40) |
| Beta Amyloid [Glu11] (10-16), human (Echelon Bioscience, CAT#641-45) |
| Beta Amyloid [Nle35] (1-40), human (Echelon Bioscience, CAT#641-13) |
| Beta Amyloid (1-16) [Gln11], human (Echelon Bioscience, CAT#641-35) |
| Beta Amyloid (1-16), rat (Echelon Bioscience, CAT#642-36) |
| Beta Amyloid (1-28), [Gln11], human (Echelon Bioscience, CAT#641-17) |
| Beta Amyloid (1-28), rat (Echelon Bioscience, CAT#642-18) |
| Beta Amyloid (1-40), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-14) |
| Beta Amyloid (1-40), rat (Echelon Bioscience, CAT#642-10) |
| Beta Amyloid (1-42), human (Echelon Bioscience, CAT#641-15) |
| Beta Amyloid (1-42), human – HFIP (Echelon Bioscience, CAT#641-00) |
| Beta Amyloid (1-42), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-22) |
| Beta Amyloid (1-42), rat (Echelon Bioscience, CAT#642-15) |
| Beta Amyloid (10-20), human (Echelon Bioscience, CAT#641-21) |
| Beta Amyloid (12-28), human (Echelon Bioscience, CAT#641-19) |
| Beta Amyloid (13-16), human (Echelon Bioscience, CAT#641-88) |
| Beta Amyloid (16-10), reverse, human (Echelon Bioscience, CAT#641-54) |
| Beta Amyloid (17-42), human (Echelon Bioscience, CAT#641-90) |
| Beta Amyloid (22-35), human (Echelon Bioscience, CAT#641-44) |
| Beta Amyloid (25-35) [Ala28] (Echelon Bioscience, CAT#640-19) |
| Beta Amyloid (25-35) [Gly35] (Echelon Bioscience, CAT#640-21) |
| Beta Amyloid (25-35) [Nle35], human (Echelon Bioscience, CAT#641-53) |
| Beta Amyloid (26-35), human (Echelon Bioscience, CAT#641-41) |
| Beta Amyloid (27-35), human (Echelon Bioscience, CAT#641-42) |
| Beta Amyloid (28-35), human (Echelon Bioscience, CAT#641-43) |
| Beta Amyloid (35-25), reverse, human (Echelon Bioscience, CAT#641-47) |
| Beta Amyloid (40-1), reverse, human (Echelon Bioscience, CAT#641-70) |
| Beta Amyloid (42-1) reverse, human (Echelon Bioscience, CAT#641-69) |
| Beta Amyloid [Gln 22] (1-40), human (Echelon Bioscience, CAT#640-20) |
| Beta Amyloid [Gln 22] (1-42), human (Echelon Bioscience, CAT#642-30) |
| Beta Amyloid [Gln11] (1-40) , human (Echelon Bioscience, CAT#641-11) |
| Beta Amyloid [Glp3] (3-42), human (Echelon Bioscience, CAT#641-16) |
| Beta Amyloid [Glu11] (1-16) (Echelon Bioscience, CAT#641-36) |
| Beta Amyloid [Glu11] (1-38), human (Echelon Bioscience, CAT#641-25) |
| Beta Amyloid [Glu11] (1-40), human (Echelon Bioscience, CAT#641-10) |
| Beta Amyloid [Glu11] (1-40), human – HFIP (Echelon Bioscience, CAT#641-01) |
| Beta Amyloid [Glu11], (1-28), human (Echelon Bioscience, CAT#641-18) |
| Beta Endorphin, human / Beta Lipotropin (61-91), human (Echelon Bioscience, CAT#291-25) |
| Beta MSH, human (Echelon Bioscience, CAT#571-47) |
| Beta Secretase Inhibitor II (Echelon Bioscience, CAT#649-18) |
| Big Endothelin (1-38), human (Echelon Bioscience, CAT#331-30) |
| Big Endothelin (1-39), porcine (Echelon Bioscience, CAT#334-10) |
| Big Endothelin (1-39), rat (Echelon Bioscience, CAT#335-50) |
| Big Endothelin 1 [D-Val22] (16-38), human (Echelon Bioscience, CAT#331-32) |
| Big Endothelin 2 (1-37), human (Echelon Bioscience, CAT#331-40) |
| Big Gastrin, sulfated (Echelon Bioscience, CAT#471-80) |
| Bilirubin (Echelon Bioscience, CAT#F-H120) |
| Bilirubin Conjugate (Echelon Bioscience, CAT#F-H130) |
| Bilirubin dimethyl ester (Echelon Bioscience, CAT#F-H110) |
| Biliverdin Hydrochloride (Echelon Bioscience, CAT#F-H100) |
| Biotin 18:0 LysoPC (Echelon Bioscience, CAT#L-15B18) |
| Biotin Monolysocardiolipin (Echelon Bioscience, CAT#L-M16B) |
| Biotin Phosphatidylinositol (Echelon Bioscience, CAT#C-00B6) |
| Biotin Phosphatidylinositol 3-phosphate (Echelon Bioscience, CAT#C-03B6) |
| Biotin Phosphatidylinositol 3,4-bisphosphate (Echelon Bioscience, CAT#C-34B6) |
| Biotin Phosphatidylinositol 3,5-bisphosphate (Echelon Bioscience, CAT#C-35B6) |
| Biotin Phosphatidylinositol 4-phosphate (Echelon Bioscience, CAT#C-04B6) |
| Biotin Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45B6) |
| Biotin Phosphatidylinositol 5-phosphate (Echelon Bioscience, CAT#C-05B6) |
| Biotin PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6) |
| Biotin Sphingomyelin (Echelon Bioscience, CAT#S-400B) |
| biotin-C12-ether LBPA (Echelon Bioscience, CAT#L-B1B12) |
| Biotin-Cardiolipin (Echelon Bioscience, CAT#L-C16B) |
| Biotin-Ceramide (Echelon Bioscience, CAT#S-300B) |
| Biotin-Lactosylceramide (Echelon Bioscience, CAT#S-600B) |
| Biotin-monolysocardiolipin (Echelon Bioscience, CAT#L-MB16) |
| Biotin-Phosphatidic Acid (Echelon Bioscience, CAT#L-41B16) |
| Biotin-Phosphatidylcholine (Echelon Bioscience, CAT#L-11B16) |
| Biotin-Phosphatidylethanol (12:0/18:1) (Echelon Bioscience, CAT#L-60B18) |
| Biotin-Phosphatidylethanol (6:0/16:0) (Echelon Bioscience, CAT#L-60B16) |
| Biotin-Phosphatidylethanolamine (Echelon Bioscience, CAT#L-21B6) |
| Biotin-Phosphatidylglycerol (Echelon Bioscience, CAT#L-51B16) |
| Biotin-Phosphatidylserine (Echelon Bioscience, CAT#L-31B16) |
| Biotinyl-alpha MSH [Nle4,DPhe7] (Echelon Bioscience, CAT#570-46) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-B345B) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-B345) |
| Biotinylated Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-B034) |
| Biotinylated Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-B045) |
| Biotinylated Select-HA 1000k (Echelon Bioscience, CAT#HYA-B1000-200) |
| Biotinylated Select-HA 250k (Echelon Bioscience, CAT#HYA-B250-200) |
| Biotinylated Select-HA 500k (Echelon Bioscience, CAT#HYA-B500-200) |
| Biotinylated Select-HA 50k (Echelon Bioscience, CAT#HYA-B50-200) |
| Biotinylated Versican G1 Domain (Echelon Bioscience, CAT#G-HA02) |
| Bisepoxy Juvenile Hormone III (Echelon Bioscience, CAT#S-0157) |
| BOC-Lys(Ac)-AMC (Histone Deacetylase (HDAC) Substrate) (Echelon Bioscience, CAT#888-20) |
| Boc-Val-Gly-Arg-bNA (Plasminogen Activator Substrate) (Echelon Bioscience, CAT#875-17) |
| BOC-Val-Pro-Arg-AFC (Thrombin substrate, fluorogenic) (Echelon Bioscience, CAT#885-11) |
| BODIPY FL Phosphatidylinositol (Echelon Bioscience, CAT#C-00F6) |
| BODIPY FL Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45F6) |
| BODIPY FL PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6) |
| BODIPY FL PI(3,4)P2 (Echelon Bioscience, CAT#C-34F6) |
| BODIPY FL PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6) |
| BODIPY FL PI(3)P (Echelon Bioscience, CAT#C-03F6) |
| BODIPY FL PI(4)P (Echelon Bioscience, CAT#C-04F6) |
| BODIPY FL PI(5)P (Echelon Bioscience, CAT#C-05F6) |
| Bodipy Labeled PIP Sample Pack (Echelon Bioscience, CAT#C-99F6) |
| BODIPY TMR Phosphatidylinositol (Echelon Bioscience, CAT#C-00M6) |
| BODIPY TMR PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6) |
| BODIPY TMR PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6) |
| BODIPY TMR PI(3,5)P2 (Echelon Bioscience, CAT#C-35M6) |
| BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6) |
| BODIPY TMR PI(4,5)P2 (Echelon Bioscience, CAT#C-45M6) |
| BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6) |
| BODIPY TMR PI(5)P (Echelon Bioscience, CAT#C-05M6) |
| BODIPY-FL PEth (Echelon Bioscience, CAT#L-60F18) |
| Bombesin (Echelon Bioscience, CAT#177-25) |
| Bovine Adrenal Medulla Docosapeptide / BAM 22P (Echelon Bioscience, CAT#313-45) |
| Bovine Thrombin (Echelon Bioscience, CAT#E-9000) |
| Bradykinin (1-7) (Echelon Bioscience, CAT#191-72) |
| Bradykinin (1-9) (Echelon Bioscience, CAT#191-25) |
| Bradykinin B2 Antagonist (HOE 140) (Echelon Bioscience, CAT#191-85) |
| Bradykinin Ile-Ser, (T-Kinin) (Echelon Bioscience, CAT#191-49) |
| Bradykinin Potentiating Factor (Angiotensin Converting Enzyme Inhibitor) (Echelon Bioscience, CAT#131-95) |
| Brain Derived Acidic Fibroblast Growth Factor (1-11), bovine (Echelon Bioscience, CAT#510-42) |
| Brain Natriuretic Peptide (BNP) (1-32), human / Brain ANP (1-32), human (Echelon Bioscience, CAT#152-52) |
| BrP-LPA (Echelon Bioscience, CAT#L-7416) |
| C-Peptide [Tyr0] / Proinsulin (32-63) Tyr0 (Echelon Bioscience, CAT#211-27) |
| C-Type Natriuretic Peptide (CNP) (1-22), human (Echelon Bioscience, CAT#151-60) |
| C6NIB (H2O2 vapor sensor) (Echelon Bioscience, CAT#D-0020) |
| Caerulein (ceruletide) (Echelon Bioscience, CAT#471-65) |
| Calcitonin Gene Related Peptide (CGRP), human (Echelon Bioscience, CAT#231-27) |
| Calcitonin Gene Related Peptide I (8-37), human / CGRP Receptor Antagonist (Echelon Bioscience, CAT#231-31) |
| Calcitonin Gene Related Peptide II (8-37), human / Beta CGRP (Echelon Bioscience, CAT#231-22) |
| Calcitonin Gene Related Peptide II (CGRP II, human), cyclic (Echelon Bioscience, CAT#231-29) |
| Calcitonin, human, cyclic (Echelon Bioscience, CAT#231-25) |
| Calcitonin, salmon (Echelon Bioscience, CAT#237-26) |
| Calcitonin, salmon [Des-Cys1] (Echelon Bioscience, CAT#237-34) |
| Calcitonin, salmon [Des-Tyr22] (Echelon Bioscience, CAT#237-32) |
| Calmodulin Binding Domain Ca2+/Calmodulin Dependent Protein (Echelon Bioscience, CAT#740-60) |
| Calmodulin Dependent Protein Kinase Substrate (Echelon Bioscience, CAT#890-81) |
| Calmodulin Kinase II Inhibitor (281-309) (Echelon Bioscience, CAT#893-40) |
| Calpastatin Peptide (Ac 184-210 ) (Echelon Bioscience, CAT#870-20) |
| cAMP Dependent Protein Kinase Inhibitor 5-24 amide (Echelon Bioscience, CAT#891-14) |
| cAMP Dependent Protein Kinase Inhibitor PKI-tide (Echelon Bioscience, CAT#892-20) |
| Cardioexcitatory Peptide, African giant snail (Echelon Bioscience, CAT#610-74) |
| Cardiolipin Beads (Echelon Bioscience, CAT#P-BCLP) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-56) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-52) |
| Cathepsin D and E substrate, fluorogenic (Echelon Bioscience, CAT#866-41) |
| Cathepsin D Substrate (Echelon Bioscience, CAT#880-42) |
| Cathepsin L Inhibitor (Echelon Bioscience, CAT#866-23) |
| Cathepsin S Substrate, fluorogenic (Echelon Bioscience, CAT#866-80) |
| CDP-ME Kinase (IspE) (Echelon Bioscience, CAT#E-2000E) |
| CDP-ME Synthase (IspD) (Echelon Bioscience, CAT#E-2000D) |
| CDP-ME Synthase (IspD) Enzymatic Assay (Echelon Bioscience, CAT#K-2000D) |
| CDP-MEP Synthesis Kit (Echelon Bioscience, CAT#K-2000E) |
| Cecropin B (Echelon Bioscience, CAT#893-50) |
| Cecropin P1, porcine (Echelon Bioscience, CAT#893-60) |
| Cell Adhesion Inhibitor Peptide, cyclic (Echelon Bioscience, CAT#451-40) |
| Cell Permeable Caspase 1 Inhibitor (Echelon Bioscience, CAT#864-38) |
| Cell Permeable Caspase 3 Inhibitor (Echelon Bioscience, CAT#864-29) |
| Cell Permeable Caspase 6 Inhibitor (Echelon Bioscience, CAT#864-31) |
| Ceramide 1-Phosphate (C1P) Beads (Echelon Bioscience, CAT#P-BC1P) |
| Ceramide Beads (Echelon Bioscience, CAT#P-BCER) |
| Ceranib-2 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0043) |
| cGMP Dep. Protein Kinase Substrate (BPDEide) (Echelon Bioscience, CAT#870-78) |
| Charybdotoxin, cyclic (Echelon Bioscience, CAT#429-60) |
| Chemotactic Peptide (Formyl-Met-Leu-Phe-OH) (Echelon Bioscience, CAT#850-15) |
| Chitin Polymer (Echelon Bioscience, CAT#H-10CH) |
| Cholecystokinin Octapeptide (26-33) / CCK 8 (Echelon Bioscience, CAT#471-47) |
| Cholecystokinin Octapeptide (26-33) Non-Sulfated / CCK-NSE O (Echelon Bioscience, CAT#471-48) |
| Cholesterol (Echelon Bioscience, CAT#L-6012) |
| Cholesterol Beads (Echelon Bioscience, CAT#P-BCHL) |
| Chromogranin A (324-337) WE 14, human (Echelon Bioscience, CAT#474-70) |
| Cionin (Echelon Bioscience, CAT#477-49) |
| Class I PI3-Kinase Reaction Buffer (Echelon Bioscience, CAT#K-KBZ) |
| Class III PI3K ELISA Kit (Echelon Bioscience, CAT#K-3000) |
| cMEPP Synthase (IspF) (Echelon Bioscience, CAT#E-2000F) |
| CML ELISA Kit II (Echelon Bioscience, CAT#K-3900S) |
| Coagulation Factor XIIIA (72-97) (Echelon Bioscience, CAT#459-15) |
| Colipase Activation Peptide (Echelon Bioscience, CAT#873-30) |
| Collagen Hybridizing Peptide – Biotin conjugate (CHP) (Echelon Bioscience, CAT#BIO) |
| Collagen Hybridizing Peptide – Cy3 Conjugate (Echelon Bioscience, CAT#RED) |
| Collagen Hybridizing Peptide – Fluorescein Conjugate (Echelon Bioscience, CAT#FLU) |
| Control Beads (Echelon Bioscience, CAT#P-B000) |
| Control PolyPIPosomes (Echelon Bioscience, CAT#Y-0000) |
| Corazonin, Periplaneta Americana (Echelon Bioscience, CAT#619-47) |
| Corticotropin Releasing Factor (CRF) human, rat (Echelon Bioscience, CAT#351-25) |
| Corticotropin Releasing Factor [Tyr0], ovine / CRF [Tyr0], o (Echelon Bioscience, CAT#352-37) |
| Corticotropin Releasing Factor, bovine, CRF, bovine (Echelon Bioscience, CAT#353-26) |
| Corticotropin Releasing Factor, ovine / CRF, ovine (Echelon Bioscience, CAT#352-26) |
| Cova PIP Screening Plate (Echelon Bioscience, CAT#H-6200) |
| CREBtide (Echelon Bioscience, CAT#890-15) |
| Cu(II) Protoporphyrin IX, 14494-37-2 (Echelon Bioscience, CAT#F-H070) |
| Custom Lipid Array Strip (Echelon Bioscience, CAT#P-6111) |
| CYM50308 (S1P4 Receptor Agonist) (Echelon Bioscience, CAT#B-0060) |
| D-erythro-Sphingosine (Echelon Bioscience, CAT#S-1000) |
| D-Ile-Pro-Arg-AMC (Echelon Bioscience, CAT#855-18) |
| D-Ile-Pro-Arg-pNA (Echelon Bioscience, CAT#855-19) |
| D-Phe-Pro-Lys-pNA (Thrombin Substrate colorimetric) (Echelon Bioscience, CAT#885-49) |
| D-sn-1-O-oleoyl-2-O-methylglyceryl-3-phosphothionate (2R-OMPT) (Echelon Bioscience, CAT#L-9318) |
| D-Val-Gly-Arg-pNA (Echelon Bioscience, CAT#855-31) |
| D-Val-Leu-Arg-AFC (Kallikrein substrate, fluorogenic) (Echelon Bioscience, CAT#871-84) |
| D-Val-Leu-Arg-AMC (Kallikrein Substrate, fluorogenic) (Echelon Bioscience, CAT#871-81) |
| D-Val-Leu-Arg-pNA (Kallikrein Substrate, colorimetric) (Echelon Bioscience, CAT#871-82) |
| D-Val-Leu-Lys-AFC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-22) |
| D-Val-Leu-Lys-AMC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-18) |
| D-Val-Leu-Lys-pNA (Plasmin substrate colorimetric) (Echelon Bioscience, CAT#872-21) |
| D-Val-Lys-Lys-Arg-AMC (Echelon Bioscience, CAT#855-44) |
| d5-PAPEth (Echelon Bioscience, CAT#L-6055) |
| d5-PLPEth (Echelon Bioscience, CAT#L-6052) |
| d5-POPEth (Echelon Bioscience, CAT#L-6051) |
| d5-SLPEth (Echelon Bioscience, CAT#L-6054) |
| d5-SOPEth (Echelon Bioscience, CAT#L-6053) |
| DAPC (20:0 PC) (Echelon Bioscience, CAT#L-1120) |
| DBPC (PLA2 Substrate) (Echelon Bioscience, CAT#L-3000) |
| Decorsin, Leech (Macrobdella decora) (Echelon Bioscience, CAT#459-10) |
| Decyl Rhamnoside (Echelon Bioscience, CAT#RL10-1) |
| Dermaseptin (Echelon Bioscience, CAT#889-15) |
| DES1 Inhibitor (Echelon Bioscience, CAT#B-0027) |
| Desmopressin, [D-Gln4] Disulfide Bridge 1-6, Acetate (Echelon Bioscience, CAT#671-18) |
| Desmopressin, [L-Arg8], Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-20) |
| Desmopressin, Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-19) |
| DHPS (6:0/6:0 PS) (Echelon Bioscience, CAT#L-3106) |
| Dibromobimane (Echelon Bioscience, CAT#F-0040) |
| Dilauroyl-sn-glycerol (Echelon Bioscience, CAT#L-0012) |
| Dimethylallyl Diphosphate (DMAPP) (Echelon Bioscience, CAT#I-0051) |
| Dimethylallyl S-Thiolodiphosphate (DMASPP) (Echelon Bioscience, CAT#I-S051) |
| Dimyristoyl-sn-glycerol (Echelon Bioscience, CAT#L-0014) |
| Dipalmitoyl-sn-glycerol (Echelon Bioscience, CAT#L-0016) |
| DLPA (12:0/12:0 PA) (Echelon Bioscience, CAT#L-4112) |
| DLPC (12:0/12:0 PC) (Echelon Bioscience, CAT#L-1112) |
| DLPE (12:0/12:0 PE) (Echelon Bioscience, CAT#L-2112) |
| DLPG (12:0/12:0 PG) (Echelon Bioscience, CAT#L-5112) |
| DMOG (dimethyloxalylglycine) (Echelon Bioscience, CAT#F-0010) |
| DMPA (14:0/14:0 PA) (Echelon Bioscience, CAT#L-4114) |
| DMPC (14:0/14:0 PC) (Echelon Bioscience, CAT#L-1114) |
| DMPE (14:0/14:0 PE) (Echelon Bioscience, CAT#L-2114) |
| DMPG (14:0/14:0 PG) (Echelon Bioscience, CAT#L-5114) |
| Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH (MMP 8 Substrate) (Echelon Bioscience, CAT#868-44) |
| Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH (MMP-2 / MMP-9 Substrate) (Echelon Bioscience, CAT#865-10) |
| DOPC (18:1/18:1 PC) (Echelon Bioscience, CAT#L-1182) |
| DOPE (18:1/18:1 PE) (Echelon Bioscience, CAT#L-2182) |
| DOPEth (18:1/18:1 PEth) (Echelon Bioscience, CAT#L-6018) |
| DPePC (Echelon Bioscience, CAT#L-1162) |
| DPPA (16:0/16:0 PA) (Echelon Bioscience, CAT#L-4116) |
| DPPC (16:0/16:0 PC) (Echelon Bioscience, CAT#L-1116) |
| DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2116) |
| DPPG (16:0/16:0 PG) (Echelon Bioscience, CAT#L-5116) |
| DPPS (16:0/16:0 PS) (Echelon Bioscience, CAT#L-3116) |
| DSPA (18:0/18:0 PA) (Echelon Bioscience, CAT#L-4118) |
| DSPC (18:0 PC) (Echelon Bioscience, CAT#L-1118) |
| DSPE (18:0/18:0 PE) (Echelon Bioscience, CAT#L-2118) |
| DSPG (18:0/18:0 PG) (Echelon Bioscience, CAT#L-5118) |
| DXP Synthase (DXS) (Echelon Bioscience, CAT#E-20DXS) |
| Dynorphin A (1-8), porcine (Echelon Bioscience, CAT#274-82) |
| Dynorphin A, porcine [Prodynorphin (209-225)] (Echelon Bioscience, CAT#274-27) |
| Dynorphin B, porcine / Rimorphin / Prodynorphin (228-240) (Echelon Bioscience, CAT#274-50) |
| ECE-1 Substrate (Echelon Bioscience, CAT#331-72) |
| Endomorphin I (Echelon Bioscience, CAT#311-88) |
| Endomorphin II (Echelon Bioscience, CAT#311-89) |
| Endothelin 2, human / ET 2 (Echelon Bioscience, CAT#331-20) |
| Endothelin 1, human (Echelon Bioscience, CAT#331-25) |
| Endothelin 3, cyclic (human, mouse, rabbit, rat) (Echelon Bioscience, CAT#335-10) |
| Endothelin Antagonist BQ 123, cyclic (Echelon Bioscience, CAT#331-10) |
| Endothelin Antagonist PD 142893 (Echelon Bioscience, CAT#331-17) |
| Endothelin Beta Receptor Agonist IRL 1620 (Echelon Bioscience, CAT#331-11) |
| Endothelin Beta Receptor Antagonist IRL 1038 (Echelon Bioscience, CAT#331-13) |
| Endothelin Receptor Antagonist BQ 3020 / Acetyl-(Ala11,15)-ET (Echelon Bioscience, CAT#331-14) |
| Endothelin Receptor Antagonist W 7338A (Echelon Bioscience, CAT#331-16) |
| Enkephalin Analog (Echelon Bioscience, CAT#311-55) |
| Enkephalinamide [D-Met2,Pro5] (Echelon Bioscience, CAT#310-47) |
| Epidermal Growth Factor (20-31) [Cys (Acm 20,31)] / EGF (Echelon Bioscience, CAT#510-50) |
| ET A Receptor Antagonist JKC 301 (Echelon Bioscience, CAT#331-51) |
| ET Antagonist PD 156252 (Echelon Bioscience, CAT#331-19) |
| ET Receptor Antagonist (PD 145065) (Echelon Bioscience, CAT#331-18) |
| Ether C12 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B120E) |
| Ether C18 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B180E) |
| Exendin 3 (Echelon Bioscience, CAT#507-79) |
| Exendin 3 (9-39) Fragment (Echelon Bioscience, CAT#507-81) |
| Exendin 4 (Echelon Bioscience, CAT#507-77) |
| ExoClean – EV Purification Kit (Echelon Bioscience, CAT#K-4300a) |
| ExoTracker – Membrane (Echelon Bioscience, CAT#K-4300b) |
| ExoTracker – RNA (Echelon Bioscience, CAT#K-4300c) |
| ExoTracker – Total (Echelon Bioscience, CAT#K-4300d) |
| Extracellular Death Factor (Echelon Bioscience, CAT#950-10) |
| Farnesyl Diphosphate (FPP) (Echelon Bioscience, CAT#I-0150) |
| Farnesyl S-Thiolodiphosphate (FSPP) (Echelon Bioscience, CAT#I-S150) |
| Fibrinogen Binding Inhibitory Peptide (Echelon Bioscience, CAT#431-55) |
| Fibrinogen Fragment (Echelon Bioscience, CAT#450-16) |
| Fibrinopeptide A [Tyr0], human (Echelon Bioscience, CAT#431-31) |
| Fibrinopeptide B [Glu1], (human) (Echelon Bioscience, CAT#431-39) |
| Fibrinopeptide B, human (Echelon Bioscience, CAT#431-36) |
| Fibronectin Fragment (Echelon Bioscience, CAT#450-59) |
| Flow PIPs: Multiplex Lipid Beads (Echelon Bioscience, CAT#P-FB01) |
| Fluorescein conjugated Anti-PI(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-G345) |
| Fluorescein conjugated Anti-PI(4,5)P2 IgM (Echelon Bioscience, CAT#Z-G045) |
| Fluorescein Monolysocardiolipin (Echelon Bioscience, CAT#L-M16F) |
| Fluorescent Carrier Pack (Echelon Bioscience, CAT#P-9CFL) |
| FPA-124 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0101) |
| FR-1, cyclic (Echelon Bioscience, CAT#450-53) |
| FR900098 (Echelon Bioscience, CAT#B-4202) |
| FS-3 (LysoPLD / Autotaxin substrate) (Echelon Bioscience, CAT#L-2000) |
| FTY720 (Echelon Bioscience, CAT#B-0720) |
| Furin Inhibitor II (Echelon Bioscience, CAT#855-10) |
| G-Subtide (Echelon Bioscience, CAT#871-15) |
| Galanin, rat (Echelon Bioscience, CAT#475-25) |
| Galanin, human (Echelon Bioscience, CAT#471-22) |
| Galanin, porcine (Echelon Bioscience, CAT#471-25) |
| Galantide (Echelon Bioscience, CAT#471-02) |
| Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-27) |
| Ganirelix (Echelon Bioscience, CAT#557-31) |
| Gastric Inhibitory Peptide (GIP), human (Echelon Bioscience, CAT#471-75) |
| Gastrin (1-17) [Gly18], human (Echelon Bioscience, CAT#471-89) |
| Gastrin (2-17) [Leu15,Gly18] / MSI 1771 (Echelon Bioscience, CAT#471-83) |
| Gastrin I (1-14) (Echelon Bioscience, CAT#471-79) |
| Gastrin I, human (Echelon Bioscience, CAT#471-73) |
| Gastrin II SE, human (Echelon Bioscience, CAT#471-74) |
| Gastrin Releasing Peptide, human / GRP, h (Echelon Bioscience, CAT#471-85) |
| Geranyl Diphosphate (GPP) (Echelon Bioscience, CAT#I-0100) |
| Geranyl S-Thiolodiphosphate (GSPP) (Echelon Bioscience, CAT#I-S100) |
| Geranylgeranyl Diphosphate (GGPP) (Echelon Bioscience, CAT#I-0200) |
| Geranylgeranyl S-thiodiphosphate (GGSPP) (Echelon Bioscience, CAT#I-S200) |
| Ghrelin (rat) (Echelon Bioscience, CAT#551-15) |
| Ghrelin, human (Echelon Bioscience, CAT#551-10) |
| GloPIPs Biotin-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6A) |
| GloPIPs Biotin-PI(3,4)P2 (Echelon Bioscience, CAT#C-34B6A) |
| GloPIPs Biotin-PI(3,5)P2 (Echelon Bioscience, CAT#C-35B6A) |
| GloPIPs Biotin-PI(3)P (Echelon Bioscience, CAT#C-03B6A) |
| GloPIPs Biotin-PI(4,5)P2 (Echelon Bioscience, CAT#C-45B6a) |
| GloPIPs Biotin-PI(4)P (Echelon Bioscience, CAT#C-04B6A) |
| GloPIPs Biotin-PI(5)P (Echelon Bioscience, CAT#C-05B6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3, C16 (Echelon Bioscience, CAT#C-39F16A) |
| GloPIPs BODIPY FL-PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2 (Echelon Bioscience, CAT#C-45F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2, C16 (Echelon Bioscience, CAT#C-45F16A) |
| GloPIPs BODIPY FL-PI(4)P (Echelon Bioscience, CAT#C-04F6A) |
| GloPIPs BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6A) |
| GloPIPs BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6A) |
| GloPIPs BODIPY TMR-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6A) |
| GloPIPs BODIPY TMR-PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2 (Echelon Bioscience, CAT#C-45M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2, C16 (Echelon Bioscience, CAT#C-45M16A) |
| GLP 2 [Gly2], human (Echelon Bioscience, CAT#471-21) |
| GLP 2 [Tyr34] (1-34), human (Echelon Bioscience, CAT#471-19) |
| GLP-1 (9-36) , Glucagon-like Peptide 1 (Echelon Bioscience, CAT#471-42) |
| Glp-Pro-Val-pNA (Human Granulocyte Elastase Substrate, colorimetric) (Echelon Bioscience, CAT#871-19) |
| Glu-His-Tyr-Gln-AMC (Echelon Bioscience, CAT#877-01) |
| Glucagon-like Peptide-1, GLP-1 (7-36) / Preproglucagon (78-107) amide (Echelon Bioscience, CAT#471-28) |
| Glucagon-like Peptide-1, GLP-1 (7-37) human (Echelon Bioscience, CAT#471-39) |
| Glucagon-like Peptide-1, GLP-1 (Preproglucagon 72-107) amide (Echelon Bioscience, CAT#471-27) |
| Glucagon-like Peptide-1, human (Echelon Bioscience, CAT#471-26) |
| Glucagon-like Peptide-2, GLP-2 (1-33), rat / Preproglucagon (126-158) (Echelon Bioscience, CAT#471-23) |
| Glucagon-like Peptide-2, GLP-2, human / Preproglucagon (126-158), human (Echelon Bioscience, CAT#471-18) |
| Glucagon, human (Echelon Bioscience, CAT#471-30) |
| Gly-Arg-Ala-Asp-Ser-Pro (GRADSP) (Echelon Bioscience, CAT#450-36) |
| Gly-Arg-Gly-Asp-Ser (GRGDS) (Echelon Bioscience, CAT#450-38) |
| Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) (Echelon Bioscience, CAT#450-39) |
| Gly-Pro-Arg-Pro-NH2 (Echelon Bioscience, CAT#450-17) |
| Glycerophosphoinositol 5-phosphate (Gro PI(5)P) (Echelon Bioscience, CAT#P-5000) |
| GMAP (1-41), amide / Galanin Message Associated Peptide (1-41), amide (Echelon Bioscience, CAT#421-35) |
| Goat anti-human Autotaxin antibody (Echelon Bioscience, CAT#Z-P400) |
| Granuliberin R (Echelon Bioscience, CAT#880-87) |
| Granzyme A Substrate, fluorogenic (Echelon Bioscience, CAT#874-13) |
| GRF (1-44)NH2, bovine (Echelon Bioscience, CAT#535-15) |
| GRF, mouse (Echelon Bioscience, CAT#536-10) |
| GRI977143 (LPA2 Agonist) (Echelon Bioscience, CAT#B-0070) |
| GroPI (Echelon Bioscience, CAT#P-0000) |
| GroPI(3,4,5)P3 (Echelon Bioscience, CAT#P-3900) |
| GroPI(4,5)P2 (Echelon Bioscience, CAT#P-4500) |
| GroPI(4)P (Echelon Bioscience, CAT#P-4000) |
| Growth Hormone Releasing Factor [D-Ala2] (1-29) amide, human (Echelon Bioscience, CAT#531-76) |
| Growth Hormone Releasing Factor [His1,Nle27] (1-32) amide, human (Echelon Bioscience, CAT#531-74) |
| Growth Hormone Releasing Factor (1-29) amide, human / GRF (1-29), amide, human (Echelon Bioscience, CAT#531-75) |
| Growth Hormone Releasing Factor (1-40) amide, human; GRF (1-40) amide, human (Echelon Bioscience, CAT#531-67) |
| Growth Hormone Releasing Factor (1-40), human; GRF (1-40), human (Echelon Bioscience, CAT#531-68) |
| Growth Hormone Releasing Factor (1-44), porcine / GRF (1-44), porcine (Echelon Bioscience, CAT#534-29) |
| Growth Hormone Releasing Factor / GRF [Ac-Tyr1,D-Arg2] (1-29) amide (Echelon Bioscience, CAT#531-84) |
| Growth Hormone Releasing Factor, GRF (1-44) amide, human (Echelon Bioscience, CAT#531-66) |
| Growth Hormone Releasing Peptide 6 (GHRP-6) / GHRP [His1, Lys6] (Echelon Bioscience, CAT#531-18) |
| HA130 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0701) |
| HA30-BODIPY-FL (Echelon Bioscience, CAT#H-025F) |
| HA30-TexasRed (Echelon Bioscience, CAT#H-025R) |
| HA300-BODIPY-FL (Echelon Bioscience, CAT#H-250F) |
| HA300-TexasRed (Echelon Bioscience, CAT#H-250R) |
| HA850-BODIPY-FL (Echelon Bioscience, CAT#H-700F) |
| HA850-TexasRed (Echelon Bioscience, CAT#H-700R) |
| Helodermin [Gln8,9] (Echelon Bioscience, CAT#740-27) |
| Hemagglutination Inhibiting Peptide, human;from parotid secr (Echelon Bioscience, CAT#790-10) |
| Heme Oxygenase Inhibitor Toolbox (Echelon Bioscience, CAT#F-HOIT) |
| Hemin (Echelon Bioscience, CAT#F-H010) |
| Heparin ELISA (Echelon Bioscience, CAT#K-5300) |
| Hepatitis C Virus NS3 Protease Substrate, fluorogenic (Echelon Bioscience, CAT#732-35) |
| Herpes Virus Inhibitor 1 (Echelon Bioscience, CAT#732-36) |
| Herpes Virus Inhibitor 2 (Echelon Bioscience, CAT#872-39) |
| Hexadecyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0320) |
| High Mobility Group Box 1 (HMGB1) (Echelon Bioscience, CAT#G-HMGB1) |
| High Throughput Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200HTS) |
| Hirudin (54-65), Sulfated (Echelon Bioscience, CAT#873-20) |
| Hirudin Acetyl (54-65) Sulfated (Echelon Bioscience, CAT#873-15) |
| Histidine Tagged Versican G1 Domain (Echelon Bioscience, CAT#G-HA03) |
| Histone H2B (29-35) (Echelon Bioscience, CAT#870-75) |
| HIV Envelope Peptide GP 120, (307-330) (Echelon Bioscience, CAT#870-26) |
| HIV Substrate IV (Echelon Bioscience, CAT#870-15) |
| HIV-1 Protease Substrate (Echelon Bioscience, CAT#870-10) |
| HIV-TAT 48-57 JNK Inhibitor I (Echelon Bioscience, CAT#732-10) |
| HS014 / MSH Antagonist cyclic / File # 0045A (Echelon Bioscience, CAT#571-72) |
| Human Lysosomal Phospholipase A2 (hLPLA2), active (Echelon Bioscience, CAT#E-7000) |
| Humanin, human (Echelon Bioscience, CAT#640-52) |
| Hy-Pip Cova PIP Specificity Plate (Echelon Bioscience, CAT#H-6300) |
| Hyaluronan Enzyme-Linked Immunosorbent Assay (HA ELISA) (Echelon Bioscience, CAT#K-1200) |
| Hyaluronic Acid (HA) Screening Service (Echelon Bioscience, CAT#T-1200) |
| Hyaluronic Acid Sandwich ELISA (Echelon Bioscience, CAT#K-4800) |
| Hyaluronidase Activity ELISA (Echelon Bioscience, CAT#K-6000) |
| Hypertrehalosaemic Neuropeptide, german cockroach (Nauphoeta (Echelon Bioscience, CAT#619-58) |
| IC87114 (PI3-K delta inhibitor) (Echelon Bioscience, CAT#B-0305) |
| IGRP Catalytic Subunit (206-214) (Echelon Bioscience, CAT#471-58) |
| Innate Defense Regulator 1018 (IDR-1018) (Echelon Bioscience, CAT#745-20) |
| Inositol 1,2,6-trisphosphate (Ins(1,2,6)P3) (Echelon Bioscience, CAT#Q-0126) |
| Inositol 1,3-bisphosphate (Ins(1,3)P2) (Echelon Bioscience, CAT#Q-0013) |
| Inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) (Echelon Bioscience, CAT#Q-0134) |
| Inositol 1,3,5-trisphosphate (Ins(1,3,5)P3) (Echelon Bioscience, CAT#Q-0135) |
| Inositol 1,4-bisphosphate (Ins(1,4)P2) (Echelon Bioscience, CAT#Q-0014) |
| Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (Echelon Bioscience, CAT#Q-0145) |
| Inositol 1,5-bisphosphate (Ins(1,5)P2) (Echelon Bioscience, CAT#Q-0015) |
| INPP4 Activity Kit (Echelon Bioscience, CAT#K-5200) |
| INPP4A, active (Echelon Bioscience, CAT#E-8000) |
| Ins(1,3,4,5)P4 (Echelon Bioscience, CAT#Q-1345) |
| Ins(1,3,4,5)P4 Beads (Echelon Bioscience, CAT#Q-B1345) |
| Ins(1,3,4,5)P4 Biotin (Echelon Bioscience, CAT#Q-139B) |
| Ins(1,3,4,6)P4 (Echelon Bioscience, CAT#Q-1346) |
| Ins(1,4,5)P3 Beads (Echelon Bioscience, CAT#Q-B0145) |
| Ins(1,4,5)P3 Biotin (Echelon Bioscience, CAT#Q-145B) |
| IP3 Receptor Inhibitor 911 [Diphenyl (2,6-diaminohexanoate-O,N)-borane] (Echelon Bioscience, CAT#B-0370) |
| Isopentenyl Diphosphate (IPP) (Echelon Bioscience, CAT#I-0050) |
| Isopentenyl S-Thiolodiphosphate (ISPP) (Echelon Bioscience, CAT#I-S050) |
| IspF Inhibitor 1 (Echelon Bioscience, CAT#B-4102) |
| Juvenile Hormone III (racemic) (Echelon Bioscience, CAT#S-0155) |
| K118 (SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0344) |
| K149 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0345) |
| Kemptide (Phosphate Acceptor Peptide) (Echelon Bioscience, CAT#870-65) |
| Ki16425 (LPA Receptor Antagonist) (Echelon Bioscience, CAT#B-0730) |
| KISS (107-121) (Echelon Bioscience, CAT#548-19) |
| KISS (112-121) (Echelon Bioscience, CAT#548-17) |
| KISS-1 (125-144) (Echelon Bioscience, CAT#548-21) |
| KISS-1 (58-65) (Echelon Bioscience, CAT#548-11) |
| KISS-1 (68-80) (Echelon Bioscience, CAT#548-13) |
| KISS-1 (68-91) (Echelon Bioscience, CAT#548-14) |
| KISS-1 (94-121) (Echelon Bioscience, CAT#548-12) |
| KP372-1 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0102) |
| L-Ascorbyl-6-stearate (Echelon Bioscience, CAT#R-1218) |
| Lactosylceramide (LacCer) Beads (Echelon Bioscience, CAT#P-B0LC) |
| Laminin (929-933) (Echelon Bioscience, CAT#736-21) |
| Laminin A (2091-2108) (Echelon Bioscience, CAT#736-10) |
| LBPA Beads (Echelon Bioscience, CAT#P-BLBPA) |
| Leu-Enkephalin (Echelon Bioscience, CAT#310-75) |
| Leu-Enkephalin [D-Ala2] (Echelon Bioscience, CAT#310-84) |
| Leucokinin I (Echelon Bioscience, CAT#341-29) |
| Leumorphin (human) (Preproenkephalin B 226-254) (Echelon Bioscience, CAT#271-35) |
| LH-RH [D-Ala6] (Echelon Bioscience, CAT#550-44) |
| LH-RH [D-Lys6] (Echelon Bioscience, CAT#550-46) |
| LH-RH [D-Lys6] Free Acid (Echelon Bioscience, CAT#551-46) |
| LH-RH [D-Phe2,D-Ala6] (Echelon Bioscience, CAT#550-45) |
| LH-RH [Hyp9] (Echelon Bioscience, CAT#557-45) |
| LH-RH Free Acid (Echelon Bioscience, CAT#551-27) |
| LH-RH II alligator, chicken (Echelon Bioscience, CAT#558-39) |
| Linolenoyl LPA, 18:3 LPA (Echelon Bioscience, CAT#L-0183) |
| Linoleoyl LPA-d5, 18:2 LPA-d5 (Echelon Bioscience, CAT#L-0182d) |
| Linoleoyl LPA, 18:2 LPA (Echelon Bioscience, CAT#L-0182) |
| Locustapyrokinin [Glu6], Locusta Migratoria (Echelon Bioscience, CAT#361-26) |
| Locustapyrokinin, L. Migratoria (Echelon Bioscience, CAT#361-25) |
| LPA Beads (Echelon Bioscience, CAT#L-6101) |
| LPA Biotin (Echelon Bioscience, CAT#L-012B) |
| LPA ELISA Assay Service (Echelon Bioscience, CAT#T-2800S) |
| LPLA2 Activity Assay (Echelon Bioscience, CAT#K-7000A) |
| LPLA2 Inhibitor Screen (Echelon Bioscience, CAT#K-7000I) |
| LPS (16:0) (Echelon Bioscience, CAT#L-3216) |
| LY294002 (PI3-K Inhibitor) (Echelon Bioscience, CAT#B-0294) |
| Lysophosphatidic Acid Antibody (504B3) (Echelon Bioscience, CAT#Z-P200) |
| Lysophosphatidic Acid ELISA Kit (Echelon Bioscience, CAT#K-2800S) |
| LysoPI, 16:0 LPI (Echelon Bioscience, CAT#P-0160) |
| Malachite Green Assay Kit (Echelon Bioscience, CAT#K-1500) |
| Malachite Green Solution (Echelon Bioscience, CAT#K-1501) |
| Mast Cell Degranulating Peptide HR-1 (Echelon Bioscience, CAT#429-35) |
| Mast Cell Degranulating Peptide HR-2 (Echelon Bioscience, CAT#429-37) |
| Mastoparan, hornet Vespa basalis (Echelon Bioscience, CAT#887-20) |
| Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH (Caspase 1 Substrate) (Echelon Bioscience, CAT#865-21) |
| Mca-Val-Asp-Val-Ala-Asp-Gly-Trp-Lys(DNP)-NH2 (Caspase 2 (ICH-1) Substrate ) (Echelon Bioscience, CAT#866-10) |
| Melanotan II, cyclic α-MSH (Echelon Bioscience, CAT#571-56) |
| Melittin (Echelon Bioscience, CAT#920-32) |
| Membrane Lipid Arrays (Echelon Bioscience, CAT#P-6003) |
| Membrane Lipid Strips (Echelon Bioscience, CAT#P-6002) |
| MeOSuc-Ala-Ala-Pro-Val-4MbNA (Pancreatic Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-19) |
| MeOSuc-Ala-Ala-Pro-Val-AFC Pancreatic Leukocyte Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-17) |
| MEP Synthase (DXR) Enzyme Inhibitor Screen (Echelon Bioscience, CAT#K-2000C) |
| MEP Synthase (DXR), active (Echelon Bioscience, CAT#E-2000C) |
| Mesobiliverdin (microbial sourced) (Echelon Bioscience, CAT#F-H160) |
| Met Enkephalin [Lys 6] (Echelon Bioscience, CAT#310-59) |
| Metastin, KISS -1 (68-121) (Echelon Bioscience, CAT#548-25) |
| Methoxysuccinyl-Ala-Ala-Arg-pNA (Echelon Bioscience, CAT#876-07) |
| Methoxysuccinyl-Pro-Ser-Pro-Phe-AMC (Echelon Bioscience, CAT#877-02) |
| Methyl glucoside sesquistearate (Echelon Bioscience, CAT#R-1018) |
| MG-115 (Proteasome Inhibitor) (Echelon Bioscience, CAT#882-10) |
| MG-132 Proteasome Inhibitor (Echelon Bioscience, CAT#882-11) |
| Miltefosine (Echelon Bioscience, CAT#L-1216) |
| Mini Gastrin I, human (Echelon Bioscience, CAT#471-11) |
| MMP 13 Substrate, fluorogenic (Echelon Bioscience, CAT#868-30) |
| MMP 14 substrate Stomelysine-3, fluorogenic (Echelon Bioscience, CAT#868-42) |
| MMP 2 Substrate, fluorogenic (Echelon Bioscience, CAT#868-20) |
| MMP Inhibitor I (Echelon Bioscience, CAT#868-75) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-22) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-41) |
| MMP-3 Inhibitor 1 (Echelon Bioscience, CAT#868-60) |
| MMP-3 Substrate, fluorogenic (Echelon Bioscience, CAT#868-62) |
| MMV008138(1R,3S) (IspD Inhibitor) (Echelon Bioscience, CAT#B-4103) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, human (Echelon Bioscience, CAT#651-10) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, rat (Echelon Bioscience, CAT#645-10) |
| MOG Protein (68-84), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, guinea pig (Echelon Bioscience, CAT#920-63) |
| Monobromobimane (Echelon Bioscience, CAT#F-0030) |
| Monocaprin (Echelon Bioscience, CAT#L-9010) |
| Monolaurin (Echelon Bioscience, CAT#L-9012) |
| Monomyristin (Echelon Bioscience, CAT#L-9014) |
| MOPC (17:0/18:1 PC) (Echelon Bioscience, CAT#L-1117) |
| MOPEth (17:0/18:1 PEth) (Echelon Bioscience, CAT#L-6017) |
| Morphine Modulating Neuropeptide (Echelon Bioscience, CAT#340-79) |
| Motilin, dog (Echelon Bioscience, CAT#496-25) |
| Motilin, human (Echelon Bioscience, CAT#491-15) |
| ms-PtdIns(4,5)P2 diC16 (Echelon Bioscience, CAT#P-F4516) |
| ms-PtdIns(4,5)P2 diC8 (Echelon Bioscience, CAT#P-F4508) |
| MultiPIP Grip (Echelon Bioscience, CAT#G-9901) |
| Myelin Proteolipid Protein (139-151) [Ser 140] (depalmitoylated), h, b, d, m, r (Echelon Bioscience, CAT#720-10) |
| Myosin Light Chain Kinase (11-19) amide (Echelon Bioscience, CAT#892-96) |
| Myosin Light Chain Kinase Substrate (Smooth muscle) (Echelon Bioscience, CAT#930-30) |
| MZ-4-169 (Echelon Bioscience, CAT#531-92) |
| MZ-4-181 (Echelon Bioscience, CAT#531-93) |
| MZ-4-71 (Echelon Bioscience, CAT#531-91) |
| N-Acetyl Beta Endorphin, human (Echelon Bioscience, CAT#291-29) |
| N-arachidonoyl-DPPE (NAPE 20:4) (Echelon Bioscience, CAT#L-2404) |
| N-Biotin Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500B) |
| N-Linoleoyl-DPPE (Echelon Bioscience, CAT#L-2420) |
| N-NBD Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500N6) |
| N-Oleoyl-DPPE (Echelon Bioscience, CAT#L-2419) |
| N-palmitoyl-DPPE (NAPE 16:0) (Echelon Bioscience, CAT#L-2416) |
| N-Stearoyl Ceramide 1-phosphate (Echelon Bioscience, CAT#S-5018) |
| N-Stearoyl-DPPE (Echelon Bioscience, CAT#L-2418) |
| nanoHA-5 (Echelon Bioscience, CAT#HYA-NANO5-1) |
| NBD-Phosphatidylethanol (Echelon Bioscience, CAT#L-60N16) |
| NeoBeads – PIP Purification System (Echelon Bioscience, CAT#P-B999) |
| Neryl Diphosphate (NPP) (Echelon Bioscience, CAT#I-0120) |
| Neurokinin A [Tyr5,DTrp6,8,9Lys10] (4-10) (Echelon Bioscience, CAT#631-70) |
| Neurokinin A [Ala5, BetaAla8],(4-10) (Echelon Bioscience, CAT#631-65) |
| Neuromedin B (Echelon Bioscience, CAT#630-62) |
| Neuromedin N (Echelon Bioscience, CAT#634-46) |
| Neuromedin U-8 (Echelon Bioscience, CAT#630-65) |
| Neuropeptide Y (3-36), human, rat / NPY (3-36) (Echelon Bioscience, CAT#614-41) |
| Neuropeptide Y (3-36), porcine / NPY (3-36) (Echelon Bioscience, CAT#614-39) |
| Neuropeptide Y (human, rat) (Echelon Bioscience, CAT#611-26) |
| Neuropeptide Y, porcine / NPY, porcine (Echelon Bioscience, CAT#614-30) |
| Neurotensin [D-Trp11] (Echelon Bioscience, CAT#631-38) |
| Neurotensin, human (Echelon Bioscience, CAT#631-27) |
| Neutral Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-1800) |
| Neutral Sphingomyelinase Assay Service (Echelon Bioscience, CAT#T-1800) |
| NFF 2 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-25) |
| NFF 3 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-10) |
| Nociceptin/Orphanin FQ (Echelon Bioscience, CAT#310-78) |
| NOG (N-oxalylglycine) (Echelon Bioscience, CAT#F-0020) |
| Non-A-Beta Component Amyloid (Echelon Bioscience, CAT#641-80) |
| Nonfluorescent Carrier Pack (Echelon Bioscience, CAT#P-9C00) |
| NVP-231 (Ceramide Kinase Inhibitor) (Echelon Bioscience, CAT#B-0040) |
| Obestatin (11-23), mouse (Echelon Bioscience, CAT#475-96) |
| Obestatin, human (Echelon Bioscience, CAT#471-97) |
| Obestatin, mouse (Echelon Bioscience, CAT#475-97) |
| Octreotide (Echelon Bioscience, CAT#690-44) |
| Oleoyl 3-carbacyclic Phosphatidic Acid (Echelon Bioscience, CAT#L-7218) |
| Oleoyl LPA, 18:1 LPA (Echelon Bioscience, CAT#L-0181) |
| Oral Formulation Vehicle (Echelon Bioscience, CAT#B-0706) |
| Orexin A (human, rat, mouse) (Echelon Bioscience, CAT#471-99) |
| Orexin A, Xenopus SS (4-10/5-12) (Echelon Bioscience, CAT#479-99) |
| Orexin B, human (Echelon Bioscience, CAT#471-98) |
| Oxyntomodulin (Glucagon 1-37) (Echelon Bioscience, CAT#471-33) |
| Oxytocin (Echelon Bioscience, CAT#670-67) |
| p-I-L-Phe4 human beta amyloid (1-40) (Echelon Bioscience, CAT#640-33) |
| P-lysoPC (16:0 LPC) (Echelon Bioscience, CAT#L-1516) |
| PACAP (1-27), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-37) |
| PACAP (1-38), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-35) |
| Palmitoyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0310) |
| Pancreastatin (1-52), human (Echelon Bioscience, CAT#481-20) |
| Pancreatic Elastase Substrate, colorimetric (Echelon Bioscience, CAT#883-18) |
| Pancreatic Leukocyte Elastase Substrate, colorimetric (Echelon Bioscience, CAT#881-15) |
| Pancreatic polypeptide bovine (Echelon Bioscience, CAT#474-21) |
| Pancreatic Polypeptide, avian (Echelon Bioscience, CAT#478-40) |
| PAPEth (16:0/20:4 PEth) (Echelon Bioscience, CAT#L-6024) |
| PAR (1-6) amide [Ala1], Mouse (Echelon Bioscience, CAT#875-28) |
| PAR-1 agonist (Echelon Bioscience, CAT#875-27) |
| PAR-2 (1-6)amide human (Echelon Bioscience, CAT#875-23) |
| Parathyroid Hormone (PTH) (1-34), human (Echelon Bioscience, CAT#231-40) |
| Parathyroid Hormone (PTH) (1-34), rat (Echelon Bioscience, CAT#235-36) |
| Parathyroid Hormone (PTH) (2-34), human (Echelon Bioscience, CAT#231-43) |
| Parathyroid Hormone (PTH) (3-34), human (Echelon Bioscience, CAT#231-46) |
| Parathyroid Hormone (PTH) (39-68), human (Echelon Bioscience, CAT#231-50) |
| Parathyroid Hormone (PTH) (39-84), human (Echelon Bioscience, CAT#231-55) |
| Parathyroid Hormone (PTH) (4-34), human (Echelon Bioscience, CAT#231-48) |
| Parathyroid Hormone (PTH) (5-34), human (Echelon Bioscience, CAT#231-51) |
| Parathyroid Hormone (PTH) (53-84), human (Echelon Bioscience, CAT#231-60) |
| Parathyroid Hormone (PTH) [Nle8,18,Tyr34] (3-34), amide, bovine (Echelon Bioscience, CAT#233-35) |
| Parathyroid Hormone [Nle8,18,Tyr34](1-34) amide, bovine (Echelon Bioscience, CAT#233-32) |
| PC Lipid Microparticles (Echelon Bioscience, CAT#P-B1PC) |
| PC/PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PCPS) |
| PDQ, Antimicrobial Peptide from Xenopus Laevis (Echelon Bioscience, CAT#745-10) |
| Peptide YY, PYY (3-36) , canine , mouse , porcine , rat (Echelon Bioscience, CAT#490-56) |
| Peptide YY, PYY (3-36), human (Echelon Bioscience, CAT#490-11) |
| PF-543 (Sphingosine Kinase I Inhibitor) (Echelon Bioscience, CAT#B-0026) |
| PF-8380 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0702) |
| Phe-Met-Arg-D-Phe-NH2 (Echelon Bioscience, CAT#610-49) |
| Phe-Met-Arg-Phe-NH2 (FMRF Peptide) (Echelon Bioscience, CAT#610-44) |
| Pheromonotropin, Pseudalatia (Echelon Bioscience, CAT#782-10) |
| PHI, rat (Echelon Bioscience, CAT#495-25) |
| Phosphatase Substrate (Echelon Bioscience, CAT#871-70) |
| Phosphatidic Acid (PA) Beads (Echelon Bioscience, CAT#P-B0PA) |
| Phosphatidylcholine (PC) Beads (Echelon Bioscience, CAT#P-B0PC) |
| Phosphatidylethanol (PEth) Beads (Echelon Bioscience, CAT#P-BPETH) |
| Phosphatidylethanol (PEth) ELISA (Echelon Bioscience, CAT#K-5000) |
| Phosphatidylethanolamine (PE) Beads (Echelon Bioscience, CAT#P-B0PE) |
| Phosphatidylinositol 4,5-bisphosphate 18:0/20:4 (Echelon Bioscience, CAT#P-4524) |
| Phosphatidylinositol diC16 (PI diC16) (Echelon Bioscience, CAT#P-0016) |
| Phosphatidylinositol diC4 (PI diC4) (Echelon Bioscience, CAT#P-0004) |
| Phosphatidylinositol diC8 (ammonium salt) (Echelon Bioscience, CAT#P-0008A) |
| Phosphatidylinositol diC8 (PI diC8) (Echelon Bioscience, CAT#P-0008) |
| Phosphatidylserine (PS) Beads (Echelon Bioscience, CAT#P-B0PS) |
| Phospholipase A2 activating peptide (Echelon Bioscience, CAT#495-26) |
| PI PolyPIPosomes (Echelon Bioscience, CAT#Y-P000) |
| PI-103 (PI3-K alpha Inhibitor 1) (Echelon Bioscience, CAT#B-0303) |
| PI(3,4,5)P3 17:0/16:0 (Echelon Bioscience, CAT#P-3917) |
| PI(3,4,5)P3 18:0/20:4 (Echelon Bioscience, CAT#P-3924) |
| PI(3,4,5)P3 diC16 (Echelon Bioscience, CAT#P-3916) |
| PI(3,4,5)P3 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3916A) |
| PI(3,4,5)P3 diC4 (Echelon Bioscience, CAT#P-3904) |
| PI(3,4,5)P3 diC8 (Echelon Bioscience, CAT#P-3908) |
| PI(3,4,5)P3 Grip (Grp1-PH) (Echelon Bioscience, CAT#G-3901) |
| PI(3,4,5)P3 PIP Beads (Echelon Bioscience, CAT#P-B345A) |
| PI(3,4,5)P3 PolyPIPosomes (Echelon Bioscience, CAT#Y-P039) |
| PI(3,4)P2 diC16 (Echelon Bioscience, CAT#P-3416) |
| PI(3,4)P2 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3416A) |
| PI(3,4)P2 diC4 (Echelon Bioscience, CAT#P-3404) |
| PI(3,4)P2 diC8 (Echelon Bioscience, CAT#P-3408) |
| PI(3,4)P2 Mass ELISA (Echelon Bioscience, CAT#K-3800) |
| PI(3,4)P2 PIP Beads (Echelon Bioscience, CAT#P-B034A) |
| PI(3,4)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P034) |
| PI(3,5)P2 diC16 (Echelon Bioscience, CAT#P-3516) |
| PI(3,5)P2 diC4 (Echelon Bioscience, CAT#P-3504) |
| PI(3,5)P2 diC8 (Echelon Bioscience, CAT#P-3508) |
| PI(3,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B035A) |
| PI(3,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P035) |
| PI(3)P diC16 (Echelon Bioscience, CAT#P-3016) |
| PI(3)P diC4 (Echelon Bioscience, CAT#P-3004) |
| PI(3)P diC8 (Echelon Bioscience, CAT#P-3008) |
| PI(3)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-3008A) |
| PI(3)P Grip (p40 PX) (Echelon Bioscience, CAT#G-0302) |
| PI(3)P Mass ELISA (Echelon Bioscience, CAT#K-3300) |
| PI(3)P PIP Beads (Echelon Bioscience, CAT#P-B003A) |
| PI(3)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P003) |
| PI(4,5)P2 diC16 (Echelon Bioscience, CAT#P-4516) |
| PI(4,5)P2 diC4 (Echelon Bioscience, CAT#P-4504) |
| PI(4,5)P2 diC8 (Echelon Bioscience, CAT#P-4508) |
| PI(4,5)P2 Grip (PLC-d1-PH) (Echelon Bioscience, CAT#G-4501) |
| PI(4,5)P2 Mass ELISA Kit (Echelon Bioscience, CAT#K-4500) |
| PI(4,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B045A) |
| PI(4,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P045) |
| PI(4)P 5-Kinase (PIP5KI) Activity Assay (Echelon Bioscience, CAT#K-5700) |
| PI(4)P diC16 (Echelon Bioscience, CAT#P-4016) |
| PI(4)P diC4 (Echelon Bioscience, CAT#P-4004) |
| PI(4)P diC8 (Echelon Bioscience, CAT#P-4008) |
| PI(4)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-4008A) |
| PI(4)P Grip (SidC-3C) (Echelon Bioscience, CAT#G-0402) |
| PI(4)P Mass ELISA Kit (Echelon Bioscience, CAT#K-4000E) |
| PI(4)P PIP Beads (Echelon Bioscience, CAT#P-B004A) |
| PI(4)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P004) |
| PI(5)P 4-Kinase (PIP4KII) Activity Assay (Echelon Bioscience, CAT#K-5400) |
| PI(5)P diC16 (Echelon Bioscience, CAT#P-5016) |
| PI(5)P diC4 (Echelon Bioscience, CAT#P-5004) |
| PI(5)P diC8 (Echelon Bioscience, CAT#P-5008) |
| PI(5)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-5008A) |
| PI(5)P PIP Beads (Echelon Bioscience, CAT#P-B005A) |
| PI(5)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P005) |
| PI3-K alpha Inhibitor 2 (Echelon Bioscience, CAT#B-0304) |
| PI3-K Alpha Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300A) |
| PI3-K Beta Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300B) |
| PI3-Kinase Activity AlphaScreen Assay (Echelon Bioscience, CAT#K-1300) |
| PI3-Kinase Activity ELISA: Pico (Echelon Bioscience, CAT#K-1000S) |
| PI3-Kinase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1100) |
| PI3-Kinase alpha (PI3Ka), active (Echelon Bioscience, CAT#E-2000) |
| PI3K (p110alpha/p85alpha), active (Echelon Bioscience, CAT#P27-18H) |
| PI3K (p110beta/p85alpha), active (Echelon Bioscience, CAT#P28-102H) |
| PI3Ka, E545K – Active Mutant (Echelon Bioscience, CAT#P27-15H) |
| PI4-Kinase Activity Assay (Echelon Bioscience, CAT#K-4000K) |
| PI4-Kinase beta (PI4Kb), active (Echelon Bioscience, CAT#P32-102G) |
| PI4-Kinase II alpha (PI4KIIa), active (Echelon Bioscience, CAT#P21-10G) |
| PI4-Kinase II beta (PI4KIIb), active (Echelon Bioscience, CAT#P22-10G) |
| PIK-93 (PI4KIIIb inhibitor) (Echelon Bioscience, CAT#B-0306) |
| PIP Array – Lipid-Protein Interaction Assay (Echelon Bioscience, CAT#P-6100) |
| PIP Beads Sample Pack (Echelon Bioscience, CAT#P-B00S) |
| PIP Pack (Echelon Bioscience, CAT#P-P100) |
| PIP Strips (Echelon Bioscience, CAT#P-6001) |
| PIP3 Mass ELISA Kit (Echelon Bioscience, CAT#K-2500S) |
| PKA Inhibitor (Echelon Bioscience, CAT#867-10) |
| PKA Substrate (Echelon Bioscience, CAT#866-25) |
| PKC Isoenzyme Inhibitor (myristoylated) (Echelon Bioscience, CAT#880-17) |
| PKC Isoenzyme Inhibitor / PKC Y translocation peptide (Echelon Bioscience, CAT#880-15) |
| PKC(e) Translocation Inhibitor – negative control (Echelon Bioscience, CAT#880-69) |
| PKG Substrate, Glasstide, H2Btide (Echelon Bioscience, CAT#870-74) |
| PKI (5-24), PKA Inhbibitor (Echelon Bioscience, CAT#890-98) |
| Plasmepsin II substrate (Echelon Bioscience, CAT#871-13) |
| PLPC (16:0/12:0 PC) (Echelon Bioscience, CAT#L-1612) |
| PLPC (16:0/18:2 PC) (Echelon Bioscience, CAT#L-1122) |
| PLPEth (16:0/18:2 PEth) (Echelon Bioscience, CAT#L-6020) |
| Pneumadin, rat (Echelon Bioscience, CAT#675-85) |
| PNPP Substrate & Solution (Echelon Bioscience, CAT#K-1208T) |
| Poly-Selective Phosphoinositide Phosphate Antibody (Echelon Bioscience, CAT#Z-P999) |
| POPC (16:0/18:1 PC) (Echelon Bioscience, CAT#L-1618) |
| POPEth (16:0/18:1 PEth) (Echelon Bioscience, CAT#L-6019) |
| Porphobilinogen (Echelon Bioscience, CAT#F-H020) |
| PPlases Substare, fluorogenic (Echelon Bioscience, CAT#869-20) |
| PPLases Substrate, colorimetric (Echelon Bioscience, CAT#869-10) |
| ProAM N20, human / Proadrenomedullin N-term 20 Peptide, huma (Echelon Bioscience, CAT#331-81) |
| ProAM N20, rat / Proadrenomedullin N terminal 20 peptide, rat (Echelon Bioscience, CAT#335-81) |
| Prodynorphin 228-256 (porcine) (Dynorphin B 29, Leumorphin) (Echelon Bioscience, CAT#274-56) |
| Propargyl-farnesol (Echelon Bioscience, CAT#S-0160) |
| Propargyl-geraniol (Echelon Bioscience, CAT#S-0110) |
| Prostate Specific Antigen Substrate (Echelon Bioscience, CAT#891-15) |
| Prot. Kin. C Pseudosubstrate Inhibitor (Echelon Bioscience, CAT#890-91) |
| Protein Kinase C (19-31), Protein Kinase C pseudosubstrate, (Echelon Bioscience, CAT#871-20) |
| Protein Kinase C Substrate (Echelon Bioscience, CAT#890-82) |
| Protein Kinase C substrate from EGF Receptor (Echelon Bioscience, CAT#871-55) |
| Protein Kinase Inhibitor Cdk2 (Echelon Bioscience, CAT#871-87) |
| Protein Tyrosine Phosphatase Substrate, fluorogenic (Echelon Bioscience, CAT#871-62) |
| Protoporphyrin IX (Echelon Bioscience, CAT#F-H050) |
| PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PS) |
| PS48 (PDK1 Activator) (Echelon Bioscience, CAT#B-0360) |
| PtdIns PIP Beads (Echelon Bioscience, CAT#P-B001) |
| PtdIns(4,5)P2 a-fluorovinylphosphate diC8 (Echelon Bioscience, CAT#P-FV4508) |
| PTEN Activity ELISA Kit (Echelon Bioscience, CAT#K-4700) |
| PTEN Enzyme, active (Echelon Bioscience, CAT#E-3000) |
| PTH Related Peptide (7-34) amide, human (Echelon Bioscience, CAT#231-94) |
| PTH Related Peptide [Asn10,Leu11] (7-34) amide, human (Echelon Bioscience, CAT#231-95) |
| PTH Related Peptide [Leu11, DTrp12] (7-34) amide, human (Echelon Bioscience, CAT#231-96) |
| PTH Related protein (1-40); Hypercalcemia Malignancy Factor (Echelon Bioscience, CAT#231-85) |
| Purified Anti-LPLA2 Antibody (Echelon Bioscience, CAT#Z-PLPLA2) |
| Purified Anti-Phosphatidylethanol Antibody (Echelon Bioscience, CAT#Z-PETH) |
| Purified Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-P345B) |
| Purified Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-P345) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034B) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034) |
| Purified Anti-PtdIns(3,5)P2 IgG (Echelon Bioscience, CAT#Z-P035) |
| Purified Anti-PtdIns(3)P IgG (Echelon Bioscience, CAT#Z-P003) |
| Purified Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-P045) |
| Purified Anti-PtdIns(4)P IgM (Echelon Bioscience, CAT#Z-P004) |
| Purified Mouse Anti-LBPA (BMP) (Echelon Bioscience, CAT#Z-PLBPA) |
| Rabbit Anti-Human DGK Zeta Antibody (Echelon Bioscience, CAT#Z-DGKZ) |
| Ranakinin, frog (Echelon Bioscience, CAT#361-50) |
| Renin Substrate I (Echelon Bioscience, CAT#131-20) |
| Resveratrol (Echelon Bioscience, CAT#B-0021) |
| Rha(rac)C10C10 (Echelon Bioscience, CAT#RL10105) |
| Rha(rac)C12C12 (Echelon Bioscience, CAT#RL12125) |
| RR-SRC, Insulin receptor kinase substrate (Echelon Bioscience, CAT#870-68) |
| S-lysoPC, (18:0 LPC) (Echelon Bioscience, CAT#L-1518) |
| S1P Beads (Echelon Bioscience, CAT#S-6110) |
| S1P Fluorescein (Echelon Bioscience, CAT#S-200F) |
| S1P Lyase Fluorogenic Substrate (Echelon Bioscience, CAT#S-200U) |
| S1P TAMRA (Echelon Bioscience, CAT#S-200T) |
| S32826 [4-(Tetradecanoylamino)benzyl]phosphonic acid disodium salt] (Echelon Bioscience, CAT#L-3282) |
| S6 Phosphate Acceptor Peptide (Echelon Bioscience, CAT#890-72) |
| Sarafotoxin 6b (Echelon Bioscience, CAT#339-10) |
| Sarilesin – Angiotensin II [Sar1,Ile8] (Echelon Bioscience, CAT#131-63) |
| Sauvagine, frog (Echelon Bioscience, CAT#357-26) |
| SDT1 (Pyrimidine 5′-nucleotidase) (Echelon Bioscience, CAT#E-20SDT1) |
| Select-HA 1000k (Echelon Bioscience, CAT#HYA-1000KEF-1) |
| Select-HA 500k (Echelon Bioscience, CAT#HYA-500KEF-1) |
| Select-HA 50k (Echelon Bioscience, CAT#HYA-50KEF-1) |
| Select-HA 601k (Echelon Bioscience, CAT#HYA-601KEF-1) |
| Select-HA HiLadder (Echelon Bioscience, CAT#HYA-HILAD-20) |
| Select-HA LoLadder (Echelon Bioscience, CAT#HYA-LOLAD-20) |
| Senktide ;Substance P [Suc-,Asp6,Me-Phe8] (6-11) (Echelon Bioscience, CAT#712-14) |
| SF1670 (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0350) |
| Sheep Anti-Human DGK Alpha Peptide Antibody (Echelon Bioscience, CAT#Z-DGKA) |
| SHIP2 Lipid Phosphatase Enzyme, active (Echelon Bioscience, CAT#E-1000) |
| SHIP2 Reaction Buffer (Echelon Bioscience, CAT#K-S2RB) |
| Shuttle PIP Kit, PtdIns(3,4,5)P3 (Echelon Bioscience, CAT#P-9039) |
| Shuttle PIP Kit, PtdIns(3,4)P2 (Echelon Bioscience, CAT#P-9034) |
| Shuttle PIP Kit, PtdIns(3,5)P2 (Echelon Bioscience, CAT#P-9035) |
| Shuttle PIP Kit, PtdIns(3)P (Echelon Bioscience, CAT#P-9003) |
| Shuttle PIP Kit, PtdIns(4,5)P2 (Echelon Bioscience, CAT#P-9045) |
| Shuttle PIP Kit, PtdIns(4)P (Echelon Bioscience, CAT#P-9004) |
| Shuttle PIP Kit, PtdIns(5)P (Echelon Bioscience, CAT#P-9005) |
| SKI-178 (SPHK1 Inhibitor) (Echelon Bioscience, CAT#B-0028) |
| SLPEth (18:0/18:2 PEth) (Echelon Bioscience, CAT#L-6022) |
| SMPC (18:0/14:0 PC) (Echelon Bioscience, CAT#L-1814) |
| sn-1-Fluorescein-labeled Cardiolipin (Echelon Bioscience, CAT#L-C16F) |
| Sn(IV) Protoporphyrin IX, 14325-05-4 (Echelon Bioscience, CAT#F-H080) |
| SNP-1 (Echelon Bioscience, CAT#888-10) |
| Somatostatin 28 (1-12) (Echelon Bioscience, CAT#691-77) |
| Somatostatin 28, cyclic (Echelon Bioscience, CAT#691-65) |
| Somatostatin Antagonist, cyclic / Coy (Echelon Bioscience, CAT#691-63) |
| Somatostatin, cyclic (Echelon Bioscience, CAT#691-25) |
| SOPEth (18:0/18:1 PEth) (Echelon Bioscience, CAT#L-6021) |
| Sorbitan monostearate (Echelon Bioscience, CAT#R-1318) |
| Spantide ([D-Arg1,D-Trp7,9,Substance P Leu11] (Echelon Bioscience, CAT#712-31) |
| Spantide II (Echelon Bioscience, CAT#712-36) |
| Specific NFAT Inhibitor / VIVIT-16 (Echelon Bioscience, CAT#887-16) |
| Sperm Activating Peptide, Sea Urchin (Echelon Bioscience, CAT#610-52) |
| Sphinganine-biotin (Echelon Bioscience, CAT#S-110B) |
| Sphinganine-fluorescein (Echelon Bioscience, CAT#S-110F) |
| Sphingo Arrays (Echelon Bioscience, CAT#S-6001) |
| Sphingo Beads (Echelon Bioscience, CAT#S-6100) |
| Sphingo Beads Sample Pack (Echelon Bioscience, CAT#P-B00SS) |
| Sphingo Strips (Echelon Bioscience, CAT#S-6000) |
| Sphingomyelin Beads (Echelon Bioscience, CAT#P-B0SM) |
| Sphingosine 1-Phosphate (S1P) (Echelon Bioscience, CAT#S-2000) |
| Sphingosine 1-Phosphate Antibody (Echelon Bioscience, CAT#Z-P300) |
| Sphingosine 1-Phosphate Assay Service (Echelon Bioscience, CAT#T-1900) |
| Sphingosine 1-phosphate biotin (S1P-biotin) (Echelon Bioscience, CAT#S-200B) |
| Sphingosine 1-Phosphate ELISA Kit (Echelon Bioscience, CAT#K-1900) |
| Sphingosine 1-Phosphate Lyase Overexpression Lysate, active (Echelon Bioscience, CAT#E-5000L) |
| Sphingosine 1-Phosphate Lyase, active (Echelon Bioscience, CAT#E-5000P) |
| Sphingosine kinase 1, active (Echelon Bioscience, CAT#E-K068) |
| Sphingosine kinase 2, active (Echelon Bioscience, CAT#E-K069) |
| Sphingosine Kinase Activity Assay (Echelon Bioscience, CAT#K-3500) |
| Sphingosine Kinase Inhibitor (SKI-II) (Echelon Bioscience, CAT#B-0024) |
| Sphingosine-biotin (Echelon Bioscience, CAT#S-100B) |
| Sphingosine-fluorescein (Echelon Bioscience, CAT#S-100F) |
| Sphingosine-tetramethylrhodamine (Echelon Bioscience, CAT#S-100T) |
| Squalene, purified (Echelon Bioscience, CAT#S-0300) |
| SS14 Tumor Inhibitor Analog (Echelon Bioscience, CAT#691-60) |
| Stercobilin Hydrochloride (Echelon Bioscience, CAT#F-H150) |
| Substance P (Echelon Bioscience, CAT#711-25) |
| Substance P (5-11) / Hepta-Substance P (Echelon Bioscience, CAT#711-66) |
| Substance P [Nle11] (Echelon Bioscience, CAT#711-36) |
| Substance P [Sar9] (Echelon Bioscience, CAT#711-48) |
| Substance P [Tyr8] (Echelon Bioscience, CAT#711-33) |
| Substance P, (p-Cl-Phe7,8) (Echelon Bioscience, CAT#712-55) |
| Substrate for E. Coli Leader Peptidase (Echelon Bioscience, CAT#887-10) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-77) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-78) |
| Suc-Ala-Ala-Ala-Ala-pNA (Echelon Bioscience, CAT#876-02) |
| Suc-Ala-Ala-Leu-pNA (Echelon Bioscience, CAT#876-03) |
| Suc-Ala-Ala-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-32) |
| Suc-Ala-Ala-Pro-Phe-AFC (Pancreatic Elastase Substrate (human), fluorogenic) (Echelon Bioscience, CAT#881-34) |
| Suc-Ala-Ala-Pro-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-31) |
| Suc-Ala-Ala-Pro-Phe-pNA (Pancreatic Leukocyte Elastase (human) Substrate, colorimetric) (Echelon Bioscience, CAT#881-30) |
| Suc-Gly-Gly-Phe-pNA (Chymotrypsin Substrate , colorimetric) (Echelon Bioscience, CAT#881-33) |
| Suc-Leu-Leu-Val-Tyr-AFC (Chymotrypsin like Enzyme Substrate, fluorogenic) (Echelon Bioscience, CAT#881-21) |
| Suc-Leu-Leu-Val-Tyr-AMC (Proteosome Substrate) (Echelon Bioscience, CAT#881-18) |
| Suc-Leu-Tyr-4-methoxy-2-naphthylamide (Calpain I & II, Papain Substrate, fluorogenic) (Echelon Bioscience, CAT#878-01) |
| Suc-Phe-Ala-His-Phe-AMC (Echelon Bioscience, CAT#877-10) |
| Suc-Phe-Ala-His-Phe-pNA (Echelon Bioscience, CAT#876-04) |
| Synthetic 16:0 Cardiolipin (Echelon Bioscience, CAT#L-C160) |
| Synthetic 16:0 Monolysocardiolipin (Echelon Bioscience, CAT#L-M160) |
| Syntide 2, CaMKII Substrate (Echelon Bioscience, CAT#105-77) |
| TACE Substrate (Fluorogenic) (Echelon Bioscience, CAT#860-78) |
| Thio-ccPA (Echelon Bioscience, CAT#L-7118) |
| Thrombin , Trypsin , Papain Substrate (Echelon Bioscience, CAT#920-13) |
| Thrombin Receptor Activator Peptide 6 / TRAP-6 (Echelon Bioscience, CAT#920-51) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-29) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-53) |
| Thrombin Receptor Agonist; (Echelon Bioscience, CAT#920-52) |
| Thrombin Receptor Antagonist (Echelon Bioscience, CAT#920-50) |
| Thymosin b4 (1-4) (Echelon Bioscience, CAT#885-21) |
| TMB Precipitating (Echelon Bioscience, CAT#K-TMBP) |
| TMR Labeled Carrier 1 (Neomycin B Sulfate) (Echelon Bioscience, CAT#P-9C1R) |
| TMR Labeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2R) |
| TNF coverting enzyme substrate (Echelon Bioscience, CAT#882-50) |
| Trismethoxyresveratrol (Echelon Bioscience, CAT#B-0022) |
| Tyr(PO3H2)4 Angiotensin II, human (Echelon Bioscience, CAT#131-48) |
| Tyrosine Specific Protein Kinase Inhibitor Peptide A (Echelon Bioscience, CAT#890-88) |
| Unlabeled Shuttle PIP Carrier 1 (Echelon Bioscience, CAT#P-9C1) |
| Unlabeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2) |
| Unlabeled Shuttle PIP Carrier 3 (Echelon Bioscience, CAT#P-9C3) |
| Uridine Diphosphate-Bodipy-FL (UDP-Bodipy-FL) (Echelon Bioscience, CAT#N-100F) |
| Urobilin Hydrochloride (Echelon Bioscience, CAT#F-H140) |
| Urocortin, human (Echelon Bioscience, CAT#353-10) |
| Urocortin, rat (Echelon Bioscience, CAT#353-20) |
| Urodilatin (Echelon Bioscience, CAT#151-30) |
| Uroporphyrin I dihydrochloride (Echelon Bioscience, CAT#F-H040) |
| Uroporphyrin III dihydrochloride (Echelon Bioscience, CAT#F-H030) |
| Urotensin I, carp (Echelon Bioscience, CAT#817-40) |
| Urotensin I, suckerfish (Echelon Bioscience, CAT#817-30) |
| Urotensin II, human (Echelon Bioscience, CAT#817-50) |
| Vasoactiv Intestinal Peptide [Lys1,Pro2,5,Arg3,4,Tyr6] / VI (Echelon Bioscience, CAT#491-32) |
| Vasoactive Intestinal Constrictor / Mouse Beta Endothelin / (Echelon Bioscience, CAT#337-10) |
| Vasoactive Intestinal Peptide (6-28),human, porcine, rat / V (Echelon Bioscience, CAT#491-29) |
| Vasoactive Intestinal Peptide / VIP, human, porcine, rat (Echelon Bioscience, CAT#491-25) |
| Vasopressin ( Pmp1,Tyr(Et)2,Val4,Arg8 ) cyclic (Echelon Bioscience, CAT#670-32) |
| Vasopressin [Arg8] (AVP), cyclic (Echelon Bioscience, CAT#670-18) |
| Vasopressin [Deamino-Pen1,Val4,D-Arg8] (Echelon Bioscience, CAT#670-36) |
| Vasopressin [Lys-8] (Echelon Bioscience, CAT#670-17) |
| Vasopressin [Pmp1, Tyr(0Me)2, Arg8] (Echelon Bioscience, CAT#670-24) |
| Vasotocin [Arg8] cyclic (Echelon Bioscience, CAT#670-65) |
| Versican G1 Domain (Echelon Bioscience, CAT#G-HA01) |
| VIP Antagonist [Ac-Tyr1,D-Phe2]-GRF(1-29)NH2 (Echelon Bioscience, CAT#491-41) |
| VO-OHpic (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0351) |
| VPC 23019 (S1P1/3 Antagonist) (Echelon Bioscience, CAT#B-0061) |
| Whole-Cell MEP Pathway-Selective Antibacterial Screening Assay Service (Echelon Bioscience, CAT#T-2000) |
| Wortmannin (Echelon Bioscience, CAT#B-0222) |
| XY-14 (Lipid Phosphate Phosphatase 1 Inhibitor) (Echelon Bioscience, CAT#L-9218) |
| XY-17 (LPA3 Agonist) (Echelon Bioscience, CAT#L-9118) |
| XY-4 (LPA analog) (Echelon Bioscience, CAT#L-1160) |
| Z-Ala-Ala-Asp-AFC (Cathepsin S Substrate, fluorogenic) (Echelon Bioscience, CAT#874-06) |
| Z-Ala-Arg-Arg-MbNA (Cathepsin B Substrate II, fluorogenic) (Echelon Bioscience, CAT#866-29) |
| Z-Ala-Lys-Arg-AMC (Echelon Bioscience, CAT#877-03) |
| Z-Arg-Arg-AMC (Cathepsin B substrate, fluorogenic) (Echelon Bioscience, CAT#866-30) |
| Z-Arg-Arg-MbNA (Cathepsin B Substrate, fluorogenic) (Echelon Bioscience, CAT#866-31) |
| Z-Arg-Arg-pNA (Cathepsin B substrate, colorimetric) (Echelon Bioscience, CAT#866-27) |
| Z-Asp-Glu-Val-Asp-AFC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-18) |
| Z-Asp-Glu-Val-Asp-pNA (Caspase 3 (Apopain) substrate) (Echelon Bioscience, CAT#861-20) |
| Z-Glu-Ala-Asp-CHO (Echelon Bioscience, CAT#878-05) |
| Z-Gly-Gly-Arg-AMC (Urokinase Substrate III, fluorogenic) (Echelon Bioscience, CAT#869-25) |
| Z-Gly-Gly-Leu-AMC (Proteasome Substrate, fluorogenic) (Echelon Bioscience, CAT#882-31) |
| Z-Gly-Val-Val-AMC (Echelon Bioscience, CAT#877-04) |
| Z-Ile-Glu-Thr-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-56) |
| Z-Ile-Glu-Thr-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#863-61) |
| Z-Leu-Arg-AMC (Cathepsin, Kallikrein, Falcipain II substrate, fluorogenic) (Echelon Bioscience, CAT#877-14) |
| Z-Leu-Leu-Glu-AMC (Proteasome Substrate 2, fluorogenic) (Echelon Bioscience, CAT#882-21) |
| Z-Leu-Leu-Leu-AMC (Proteasome Substrate 1, fluorogenic) (Echelon Bioscience, CAT#882-20) |
| Z-Leu-Leu-Phe-CHO (Proteasome Inhibitor 2) (Echelon Bioscience, CAT#882-12) |
| Z-Phe-Ala-pNA (Echelon Bioscience, CAT#876-05) |
| Z-Phe-Arg-AFC (Cathepsin L Substrate, fluorogenic) (Echelon Bioscience, CAT#866-75) |
| Z-Phe-Arg-AMC (Kallikrein substrate) (Echelon Bioscience, CAT#871-75) |
| Z-Phe-CHO (Echelon Bioscience, CAT#878-06) |
| Z-Phe-Tyr-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-28) |
| Z-Tyr-Val-Ala-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-17) |
| Z-Tyr-Val-Ala-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-28) |
| Z-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-49) |
| Z-Val-Gly-Arg-pNA (Urokinase Substrate I, colorimetric) (Echelon Bioscience, CAT#869-31) |
| Z-Val-Ile-Ala-AMC (IRCM Serine Protease I Substrate, fluorogenic) (Echelon Bioscience, CAT#877-05) |
| Z-Val-Lys-Met-AMC (Proteasome Substrate 4, fluorogenic) (Echelon Bioscience, CAT#882-23) |
| Z-Val-Phe-CHO (Calpain Inhibitor III) (Echelon Bioscience, CAT#870-50) |
| Z-Val-Pro-Arg-pNA (Echelon Bioscience, CAT#876-08) |
| Z-Val-Val-Arg-AFC (Echelon Bioscience, CAT#874-01) |
| Zn (II) Deuteroporphyrin IX 2,4 bisethylene glycol (Echelon Bioscience, CAT#F-H090) |
| Zn Protoporphyrin IX (Echelon Bioscience, CAT#F-H060) |
| ZSTK474 (PI3K Inhibitor) (Echelon Bioscience, CAT#B-0307) |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://peprotech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Echelon Biosciences"> Echelon Biosciences地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18327026838
传真：15172431432
邮箱：sales@amyjet.com
0.3019
